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Abstract 
Saponins are a large family of specialized metabolites produced in many plants. They can have 
negative effects on a number of plant pests and are thought to play a role in plant defense. With current 
and possible future uses in industry and agriculture, saponins have also been shown to be 
hypocholesterolemic, hypoglycemic, immunostimulatory, antioxidative, anti-inflammatory, and cytotoxic. 
In spite of their usefulness, our understanding of the genetic basis for saponin biosynthesis is still 
incomplete. We generated recombinant populations with parents from genetically distinct accessions of 
Medicago truncatula, with either high or low accumulation and varying profiles of saponins. Primers for a 
PCR-based parental test were developed from single-nucleotide polymorphisms in the sequence 
encoding CYP72A68, a cytochrome P450 enzyme involved in the biosynthesis of M.truncatula 
sapogenins. Comparison of translated CYP72A68 amino acid sequences across accessions revealed 
high similarity, and comparison with CYP72A proteins from other plant species suggests similar protein 
functioning across the accessions.  The F2 generation plants from one recombinant population were 
screened for hemolytic saponin accumulation levels in leaf extracts by measuring cleared zones in blood 
agar plates. Three distinct phenotypes were observed. Plants in the F2 generation showed either a high or 
low hemolysis phenotype matching those of the parent plants, or an intermediate level of hemolysis. The 
high:medium:low phenotypic ratio for 141 plants was 1:3:1. Quantitative RT-PCR showed a correlation 
between expression of CYP716A12, CYP72A67, and CYP72A68 genes, all encoding cytochrome P450 
enzymes involved in synthesis of hemolytic sapogenins, and the three hemolysis phenotypes. 
Concurrently, we found that treatment of Caco-2 human colon cancer cells with saponin extracts from 
four M. truncatula accessions resulted in decreased cell proliferation over time, and that this effect did not 
appear to be mediated through apoptosis induction. The saponin extracts were analyzed by HPLC-MS to 
identify individual saponins that could contribute to cytotoxic activity. Therefore, accession differences in 
M. truncatula saponin accumulation result from differential regulation of saponin synthesis gene 
expression and inheritance of these differences depends on more than a single gene with dominant and 
recessive alleles. Saponin extracts are shown to have a negative impact on cancer cell lines.  
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 Medicago truncatula triterpene saponins 
 
Introduction 
Specialized metabolism in plants 
 Plants are under constant attack by a wide variety of pests, including bacteria, fungi, nematodes, 
insects, and even mammals. Without the ability to physically escape these pests, plants have had to 
develop their own unique methods of defending themselves. One of the key defense mechanisms plants 
utilize is specialized metabolism, so named because the resulting compounds are not found in all plant 
species and are therefore not vital to the primary metabolism all plants share (Pichersky and Lewinsohn, 
2011). It is estimated that plants as a whole produce at least 200,000 different compounds through 
specialized metabolism, although no single plant species has the ability to produce the entire range of 
these compounds (Mithöfer and Boland, 2012). Instead, individual plant species have evolved the ability 
to produce the specific compounds they need to deal with the pressures of their particular ecological 
situation (Pichersky and Lewinsohn, 2011). In addition to the diversity of specialized metabolites found in 
the plant kingdom, individual plants species are able to produce a diverse range of specialized 
metabolites. This provides the plant with resistance to multiple pests and the opportunity to produce 
metabolites that can work synergistically to increase efficacy (Howe and Jander, 2008). When used 
against Spodoptera litura, the monoterpenoid plant essential oils thymol and trans-anethole are over two-
times more effective than would be expected if they worked in a purely additive manner (Hummelbrunner 
and Isman, 2001). Specialized metabolism can take place constitutively in a plant or be induced by pest 
attack (Howe and Jander, 2008). The induced response to pest attack occurs both locally at the wound 
site and systemically throughout the plant, and both constitutive and induced metabolism can provide 
direct or indirect defense (Kessler and Baldwin, 2002). Direct defenses work alone to negatively affect the 
pest’s ability to harm the plant by being toxic, antidigestive, or unpalatable, while indirect defenses work 
by attracting predators and parasitoids of the attacking herbivorous pest, usually through the production 
of volatile organic compounds (VOCs) (Mithöfer and Boland, 2012). Virtually all higher plants exhibit this 
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behavior; for example, Lotus japonicus produces a mixture of VOCs in response to spider mite damage 
that attracts the predatory mite Phytoseiulus persimilus (Ozawa et al., 2000).  
 The most important classes of specialized metabolites are the terpenoids, glucosinolates, 
flavonoids, phenolics, and alkaloids (Kliebenstein, 2012). Most relevant to this research, terpenoids 
derived from 5-carbon isoprenoid units are the most diverse class of specialized metabolites, including 
over 40,000 different described compounds. Terpenoids play many roles in the plants that produce them.  
Mono-, sesqui- and homo-terpenes serve as major components of the VOC blends many plants produce 
to attract pest parasites and predators (Mithöfer and Boland, 2012). Terpenoids can also act in a more 
direct way to simply repel pests. Transgenic Arabidopsis thaliana plants that overexpressed a terpene 
synthase gene and had increased levels of the monoterpene linalool were shown to significantly repel 
Myzus persicae aphids in a dual-choice assay (Aharoni et al., 2003). Mono- and sesqui-terpenes present 
in the resin produced by many conifers act as microbial and insect toxins (Phillips and Croteau, 1999). 
Some terpenoids, including the monoterpenes carvacrol and D-limonene, have even been shown to play 
an allelopathic role, interfering with basic plants functions such as respiration, seed germination, and the 
nitrogen cycle to deter growth and survival (Maffei et al., 2011). Besides their role in plant defense, 
terpenoids have proven to be useful to humans, exhibiting a variety of medicinal properties. Taxol, the 
widely used breast and ovarian cancer treatment, and artemisinin, an anti-malarial agent, as well as many 
promising compounds in clinical trials, such as D-limonene and β-sitosterol, are all terpenoids (Croteau et 
al., 2006; Pollier et al., 2011b; Singh and Sharma, 2014). With their chemical diversity and varied 
biological activities, specialized metabolites, and terpenoids in particular, represent a vast collection of 
compounds that could be exploited to help solve many of the problems humans face today.  
Saponins: basic structure and properties 
 Saponins are the most complex group of terpenoids in terms of diversity of family members. 
These structurally and functionally diverse compounds are made up of a carbon-rich aglycone backbone, 
often called a sapogenin, glycosidically linked to a polar sugar moiety (Lacaille-Dubois, 2007). There are 
two types of saponins, differentiated by the chemistry of their backbone structure. The aglycone 
component of steroidal saponins has a 27-carbon backbone, and that of triterpene saponins has a 30-
carbon backbone (Weng et al., 2011). Within these two groups there is opportunity for further 
	  
 3	  
differentiation. There are nine reported classes of triterpene backbones with a total of 100 individual 
backbones currently known (Moses et al., 2014a; Thimmappa et al., 2014). Saponins can also be 
grouped by the number of attached saccharide side chains. Monodesmosidic saponins contain one 
saccharide side chain attached at the C-3 position, while bidesmosidic saponins contain a second 
saccharide side chain at either the C-26 or C-28 position (Francis et al., 2002). Tridesmoside saponins 
with three saccharide side chains attached at different positions exist but are rare (Augustin et al., 2011). 
Some of the possible monosaccharide components of the side chain include glucose, xylose, galactose, 
rhamnose, glucuronic acid, and methylpentose (Francis et al., 2002).  The multiple possibilities in 
aglycone types, saccharide side chain composition, and position of saccharide side chain attachment give 
rise to the immense chemical diversity found among saponins (Francis et al., 2002). The combination of 
the lipophilic backbone with the hydrophilic sugar moiety makes saponins amphiphilic and gives them 
detergent, wetting, emulsifying, and surfactant properties (Güçlü-Üstündağ and Mazza, 2007). In fact, 
saponins were named for their ability to create stable soap-like foams in aqueous solutions; “sapo” is the 
Latin word for soap (Weng et al., 2011). A selection of steroidal and triterpene aglycone backbone are 
depicted in Figure 1. 
 
	  
Figure 1. Triterpene and steroidal saponin aglycone chemical structures. Carbon numbering of 
furostanol- and spirostanol-type steroidal saponin aglycones and triterpene aglycones representative of 




 Saponins are mainly produced by plants, but are also found in some marine organisms, insects, 
and bacteria (Thimmappa et al., 2014; Weng et al., 2011). Among plants, saponins are most prevalent 
among angiosperms (Magnoliophyta), with dicotyledonous plants accumulating primarily triterpene 
saponins, and monocotyledonous plants producing mostly steroidal saponins (Moses et al., 2014a). In 
addition, both wild plants and cultivated crops produce saponins. Triterpene saponins are more common 
in cultivated crops, while steroidal saponins are predominant in herbs and other plants with health-
promoting properties (Francis et al., 2002). The main dietary source of saponins is the legumes, including 
soybeans, chickpeas, peanuts, lentils, peas, and other beans, while cereals and grasses, with the 
exception of oats, are usually deficient in saponins (Güçlü-Üstündağ and Mazza, 2007; Moses et al., 
2014a). Due to their biological activity against many plant pathogens, pests, and herbivores and the 
ability of jasmonates to trigger their production, saponins are commonly considered to play a part in plant 
defense (Augustin et al., 2011). Saponin accumulation varies across plant organs and tissue types and 
can fluctuate according to the season, as well as a plant’s species, cultivar, and developmental stage. In 
addition, biotic stresses, such as infection or herbivory, and abiotic stresses, such as light, temperature, 
humidity and nutrient starvation, can affect saponin accumulation levels (Moses et al., 2014a). In the 
licorice plant Glycyrrhiza glabra, the medically important triterpene saponin glycyrrhizin was produced in 
higher amounts as a result of severe drought stress (Nasrollahi et al., 2014).  
 Steroidal and triterpene saponin synthesis originates in the mevalonate (MVA) pathway with the 
conversion of acetyl-CoA into the 5-carbon isopentyl pyrophosphate (IPP). Some of the IPP molecules 
are isomerized into dimethylallyl pyrophosphate (DMAPP), and then 2 IPP molecules and 1 DMAPP 
molecule condense to form 15-carbon farnesyl pyrophosphate (FPP). Two FPP molecules condense to 
form squalene, which is then epoxidized to form the linear 30-carbon 2,3 oxidosqualene. The successive 
variable cyclization of 2,3 oxidosqualene results in the production of a range of aglycone backbones and 
serves as the point of differentiation between steroidal and triterpene saponins, as well as between the 
different classes of triterpene saponin backbones. All types of the aglycone backbones then undergo a 
series of distinct oxygenation and glycosylation reactions catalyzed by different tailoring enzymes to 




 The most extensively studied property of saponins is their ability to permeabilize membranes, the 
molecular basis for their hemolytic activity (Augustin et al., 2011). The primary model for saponin-
membrane interaction involves the spontaneous incorporation of saponins into the outer layer of the 
bilayer membrane driven by the lipophilic aglycone’s affinity for the lipid interior of the membrane. The 
saponins then form 1:1 complexes with membrane sterols, and the complexes aggregate to form plaques	  
(Augustin et al., 2011; Lorent et al., 2014). The sterical nature of the plaques results in membrane 
curvature that can lead to the formation of pores that increase membrane permeability (Armah et al., 
1999) or vesiculation that carries away sterols (Elias et al., 1978). Research by Lin and Wang, 2009, 
presented an alternative model of saponin-membrane interaction in which incorporated saponins 
migrated to sterol-rich lipid rafts to complex with the cholesterol present, instead of creating sterol-rich 
plaques. Saponin-membrane interaction is influenced by characteristics of both the membrane and the 
saponins involved. Regarding the membrane, saponin interaction is affected by the presence or absence 
of cholesterol (Armah et al., 1999; Gögelein and Hüby, 1984), the concentration of cholesterol (Nishikawa 
et al., 1984; Rosenqvist et al., 1980), and the structure of the cholesterols present (Steel and Drysdale, 
1988; Walker et al., 2008). On the saponin, aglycone structure; saccharide side chain number, length, 
and composition; and the nature of aglycone-sugar and sugar-sugar linkages affects membrane 
interaction (Moses et al., 2014a). The structures of some saponins, including the oleanane-type 
triterpenoid soyasaponins in Medicago truncatula, do not afford for any hemolytic activity (Yoshiki et al., 
1998). Saponins are a chemically diverse family of specialized metabolites produced by many plants, 
including several important food crops, as a means of plant defense. They are composed of a 
hydrophobic aglycone backbone and a polar sugar moiety resulting in amphipathic properties that 
contribute to their ability to permeabilize membranes.   
Applications of saponins: industry 
Saponins are currently used in many industrial applications for the emulsifying, foaming, and 
detergent properties provided by their amphipathic character (Güçlü-Üstündağ and Mazza, 2007). Yucca 
schidigera is the most common commercial source of steroidal saponins, while Quillaja saponaria, or the 
soapbark tree, is the most common commercial source of triterpene saponins (Francis et al., 2002). The 
bark of Q. saponaria, a native of central and south Chile, contains 5% triterpenoid saponins, and a 
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conservative estimate put the annual market value of the quillaja extract industry at 7 million USD in 
1999. The indigenous people of Chile were the first to recognize the benefits of quillaja bark, placing it in 
boiling water and soaking it overnight before using the extract to wash their hair and clothes (San Martín 
and Briones, 1999). Quillaja extract toxicology studies in rats found no ill effect from consuming even up 
to 1.5 g/kg/day over 2 years (Drake et al., 1982), and quillaja extracts, as well as a saponin extracts from 
a small group of plants, have been approved for use as food additives in the United States, Japan, and 
the European Union (Güçlü-Üstündağ and Mazza, 2007). Saponin extracts are added to carbonated 
beverages because of their foaming properties, while their emulsifying properties are exploited in the 
production of mayonnaise, whipping cream, soy sauce, and candies with oil-soluble flavorings (San 
Martín and Briones, 1999). Saponins, which are generally considered to be bitter (Price et al., 1985) but 
can be sweet (Kennelly et al., 1996), are also used as flavoring agents. The saponin glycyrrhizin is 
thought to be primarily responsible for the sweetness of licorice, which is regularly added to candy, 
chewing gum, beverages, baked foods, and herbs and seasonings (Güçlü-Üstündağ and Mazza, 2007). 
There has been interest in the use of oleanolic acid as a flavoring agent in diet beverages to reduce 
aftertaste and enhance sweetness (Kang et al., 1999). Because of their varied biological activities and 
low toxicity, saponins could also be used as antimicrobials or anti-yeast agents in food. Finally, saponins 
have been used in the removal of cholesterol from dairy products (Richardson and Jimenez-Flores, 1994) 
and may be used in the elimination of fat globule membranes from whey protein concentrates to improve 
their quality for use in processed foods in the future (Hwang and Damodaran, 1994).  
Saponins are also used as additives in the cosmetics industry. Due to their surface-active and 
detergent properties, they have been added to many different personal cleansing agents including liquid 
soap, toothpaste, mouth wash, shower gel, lotions, and foam bath (Güçlü-Üstündağ and Mazza, 2007). 
Quillaja extracts have been shown to be compatible with many of the chemicals commonly used in 
shampoos including sodium laurel sulfate, methylparaben, glucamate, and propylparaben and are already 
widely used as secondary surfactants in many shampoos in Chile (San Martín and Briones, 1999). 
Saponins have also been marketed as active ingredients in cosmetic products that claimed to delay aging 
of the skin and prevent acne. The ability of saponins to form micelles in aqueous solution can increase 
the solubility of other compounds, and this property could be exploited to increase the solubility of 
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important ingredients in cosmetic, food, and pharmaceutical products (Güçlü-Üstündağ and Mazza, 
2007). Saponins have also been utilized in several other miscellaneous industrial applications, including 
as a wetting agent in the production of film, as a wastewater treatment in Japan to enhance oxygen 
transfer and fat degradation, as a component of light weight composites used in construction, and as a 
surfactant useful for washing soil contaminated with naphthalene and hexachlorobenzene (Roy et al., 
1997; San Martín and Briones, 1999). Saponins, especially from Y. schidigera and Q. saponaria, are 
currently used in many industrial applications, primarily as emulsifying, foaming, detergent, and flavoring 
agents in food and cosmetics New uses for saponins continue to be proposed, including as antimicrobials 
in food and for increasing solubility of other compounds.  
Applications of saponins: agriculture 
 Interest in exploiting saponins in agriculture, to improve both the cultivation of crops and of 
livestock, has been growing due to their biological activity. While the use of synthetic chemicals is still the 
primary method of protecting crops by deterring unwanted pests and competing plants, concerns about 
the environment, animal and human health, and decreasing effectiveness due to pest resistance have led 
many to seek alternative methods (Tava and Odoardi, 1996). Saponins have been shown to have 
insecticidal, nematicidal, allelopathic, fungicidal, antibacterial, antiviral, and mulluscidal properties and 
could be used to protect crops by either application of extracts or plant material or by bioengineering 
increased or novel saponin production (Augustin et al., 2011; Francis et al., 2002). The incorporation of 
partially purified alfalfa (Medicago sativa) saponin mixtures into an artificial diet was able to increase 
mortality for the European grape moth (Lobesia botrana) and the summer fruit tortrix moth (Adoxophyes 
orana) and inhibit larval growth and development for European corn borer (Ostrinia nubilalis), Tenebrio 
molitor, and Spodoptera littoralis larvae (Tava and Odoardi, 1996), while saponin preparations from a 
variety of legume seeds were able to inhibit development of the Azuki bean beetle (Callosobruchus 
chinensis) when ingested (Applebaum et al., 1969). Soil amendment with saponin-rich dried M. sativa 
plant material was able to significantly reduce populations of root-knot nematode (Meloidogyne incognita), 
potato cyst nematode (Globodera rostochiensis), and carrot cyst nematode (Heterodera carotae) infesting 
tomato, potato, and carrot plants, respectively, in both potted plant and field trials (D’Addabbo et al., 
2011). M. sativa medicagenic acid glycosides can act as either plant growth inhibitors or stimulators 
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depending on whether they are present at a high or low concentration, respectively (D’Addabbo et al., 
2011). Saponins extracted from the roots of M. sativa were able to significantly inhibit mycelium growth of 
the fungal plant pathogens Alternaria zinniae, Botrytis cinerea, Botrytis tulipae, Phoma narcissi, Phoma 
poolensis, and Rhizoctonia solani in vitro and inhibited development of Phoma narcissi on Hippeastrum 
leaves without causing leaf damage when administered as a preinoculation spray (Saniewska et al., 
2013).  
 Similar to the increasingly negative public opinions on the use of synthetic chemicals in crop 
cultivation, the use of antibiotics as feed additives to enhance livestock performance has come under 
increasing scrutiny due to fears of generating antibiotic resistant pathogenic bacteria. Plant-derived 
products, such as saponins, show promise as possible alternatives along with other non-antibiotic growth 
promoters like organic acids and probiotics (Windisch et al., 2008). In fact, Nutrafito Plus, a proprietary 
blend of saponin-rich yucca and quillaja plant powders, was able to improve growth, feed conversion, and 
other performance parameters in broiler chickens to a similar level as seen with antibiotic growth 
promoters (Cheeke, 2009). However, due to the chemical diversity of saponins and their varying 
biological activities in the many bodily environments of different animal species, research on the use of 
saponins as feed additives presents a complicated story, showing both positive and negative effects of 
different saponins on livestock.  
 One positive effect saponins have on ruminant livestock is defaunation, or the removal of 
protozoa through interaction with their membrane sterols, which can lead to an increase in microbial 
efficiency in the rumen (Cheeke, 1996). Ammonia-binding yucca extracts are believed to bind ammonia 
when levels are high in the rumen and then release ammonia when levels are low, maintaining a constant 
and adequate supply of ammonia in the rumen that is necessary for microbial metabolism, making 
nitrogen utilization more efficient, and lowering ammonia levels in waste, which would otherwise 
contribute to groundwater pollution and greenhouse gases (Cheeke, 2000; Francis et al., 2002; Pen et al., 
2006). Yucca saponins were also found to selectively inhibit certain bacterial species and not others in 
the rumen, opening up the possibility of using different saponins to design the microbial population of the 
rumen to maximize animal performance (Francis et al., 2002). There has been research into the use of 
yucca extracts to decrease production of methane, a source of energy loss to the animal and contributor 
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to greenhouse gas emissions, although reports are mixed. Pen et al. (2006) found that addition of yucca 
extract was able to significantly reduce methane production by up to 42% in vitro, while Holtshausen et al. 
(2009) found that feeding dairy cows a low enough amount of yucca plant powder to eliminate possible 
negative effects resulted in a loss of the positive effect of methane reduction as well. Oral administration 
of saponins may stimulate animal immune systems and strengthen disease resistance; feeding sows 
yucca extract in late pregnancy resulted in reduced neonatal pig mortality (Cheeke, 2000). Diets 
supplemented with sarsaponin resulted in increased growth in steers and increased growth, feed 
efficiency, and intake for pigs (Mader and Brumm, 1987). 
 The most basic argument against the use of saponins as feed additives is that they are 
unpalatable to many animals because of their bitter taste. Pigs and various avian species, including 
turkey and chicken, have shown an aversion to feed containing even very low levels of high-saponin 
alfalfa meal, and cattle have often shown aversions to particular batches of alfalfa hay, presumably 
because of higher levels of saponins (Cheeke, 1996). This aversion can lead to reduced feed intake and 
has led some to call for the development of saponin-free alfalfa (Dixon and Sumner, 2003). Saponins 
have also been blamed for the occurrence of ruminant bloat, although this has yet to be supported by 
clear experimental proof (Francis et al., 2002).  Early research claimed that saponins reduced surface 
tension due to their surface-active properties, leading to foam formation, and reduced ruminal motility, 
limited the rumen’s ability to clear the foam produced (Milgate and Roberts, 1995). However, later work 
failed to find a connection between the occurrence of bloat in cattle and whether they were fed a high or 
low saponin alfalfa diet (Cheeke, 1996). Certain saponins have also been shown to interfere with small 
intestinal mucosal cells in vitro, increasing their permeability and inhibiting active transport (Johnson et 
al., 1986). This could lead to the uptake of certain macromolecules, such as allergens, that would 
normally be excluded and increase the turnover rate of intestinal mucosal cells, a source of energy and 
protein loss that could explain the growth-decreasing effects of saponins some have reported (Cheeke, 
1996; Francis et al., 2002). Saponins, poorly absorbed themselves due to their binding with the intestinal 
mucosa, have also been reported to reduce absorption of different micronutrients, including vitamin A and 
E, sodium, iron, magnesium, calcium, and zinc in the diet of different animals (Cheeke, 1996; Francis et 
al., 2002). Finally, steroidal saponins have been implicated in livestock development of 
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photosensitization, a condition that occurs when UV light reacts with photodynamic compounds in the 
blood and produces free radicals that react with proteins and nucleic acids, causing severe skin lesions. 
The saponins are conjugated with glucuronic acid in the liver and excreted into the bile as insoluble 
calcium salt crystals that damage the bile ducts and disrupt bile excretion, resulting in the retention of 
phylloerythrin, a photodynamic compound, in the blood. Often, the sources of the saponins that cause this 
problem are weeds, including Tribulus terrestris, Narthecium ossifragum, and Agave lechuguilla, and not 
part of the animal’s typical diet (Cheeke, 1996). Saponins show activity against a variety of plant 
pathogens, including insects, nematodes, and fungus, and could be used to protect crops either by 
application of extracts or plant material. Saponins could also be used as feed additives to improve 
livestock performance, but the existence of studies reporting both positive and negative effects of 
saponins suggests that additional research is needed.  
Applications of saponins: human health 
 Research into the use of saponins to treat and prevent various human ailments is widespread 
due to their many pharmaceutically significant properties, most of which are very specific to saponin type 
and structure. However, saponins are not new to medicine. Various cultures have used saponin-rich 
plants such as yucca, ginseng, horse chestnut, licorice, and sarsaparilla for centuries to treat poor health; 
over 85% of the herbs used in traditional Chinese medicine contain significant amounts of saponins 
(Güçlü-Üstündağ and Mazza, 2007). Saponins are able to lower cholesterol by both interacting with 
cholesterol in the small intestine to form insoluble complexes that prevent absorption and forming mixed 
micelles with bile acids that increase their excretion and necessitate their replacement by hepatic 
synthesis from cholesterol (Sidhu and Oakenfull, 1986). This effect has been shown to selectively lower 
the more harmful LDL cholesterol in the serum of gerbils, rats, and human subjects (Francis et al., 2002) 
without changing the concentration of the healthier HDL cholesterol (Bora and Sharma, 2011). A product 
made available in the United States called Cholestaid™ containing 900 mg of saponin-rich M. sativa 
extract with 100 mg citric acid claims to “neutralize” cholesterol in the stomach and facilitate its excretion 
(Bora and Sharma, 2011). Saponins can act as adjuvants, compounds that are used in combination with 
a specific antigen to increase immunity to that antigen, and immunostimulants, substances that are used 
to induce a more generalized resistance to pathogens or tumors (Lacaille-Dubois, 2007; Sun et al., 2009). 
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Certain saponins in the form of both purified compounds and crude mixtures have been shown to induce 
specific cytotoxic T-lymphocyte responses, increase immune cell proliferation, and enhance antibody 
production (Francis et al., 2002). There is particular interest in using saponins as adjuvants in orally 
administered vaccines due to their ability to increase the permeability of intestinal cells, facilitating the 
uptake of antigens (Francis et al., 2002; Güçlü-Üstündağ and Mazza, 2007). QuilA, isolated from Q. 
saponaria bark, and its derivative QS-21 are the foremost saponin adjuvant candidates and have been 
used in formulations of vaccines in Phase I and II human trials for HIV, cancer, and malaria and in 
experimental vaccines for respiratory syncytial virus, cytomegalovirus, Toxoplasma gondii, and visceral 
leishmaniasis in mice (Lacaille-Dubois, 2007; Sun et al., 2009). Saponins have been reported to be 
hypoglycemic by a variety of mechanisms. Oleanolic acid glycosides inhibited gastric emptying, a process 
that occurs faster in type I and II diabetic patients and contributes to higher glucose levels, and glucose 
uptake at the small intestine brush border when added to the nutrient meal diet of mice (Matsuda et al., 
1999). However, a saponin-rich fenugreek seed extract fed to rats decreased blood glucose levels by 
increasing plasma insulin levels, presumably by stimulating β-cells (Petit et al., 1993). Particular saponins 
may have useful neuroprotective properties. Rg1, a Panax ginseng saponin, was able to reduce neuronal 
death through a variety of mechanisms after a hypoxic-ischemic type insult in vitro and could be used to 
protect the brain after an ischemic cerebral stroke (Zhang et al., 2008). Ginseng saponins, often called 
ginsenosides, induced nitric oxide production in the brain and inhibited stress-induced hypothalamo-
pituitary-adrenal responses (Francis et al., 2002), while the purified ginsenoside Rb1 can minimize the 
toxic effects of β-amyloid peptides present in Alzheimer’s disease (Lacaille-Dubois, 2007). Saponins have 
exhibited biological activity against important bacterial, viral, and fungal human pathogens, including 
Staphylococcus aureous, human immunodeficiency virus (HIV), herpes simplex virus (HSV), influenza 
virus, and Candida albicans (Bora and Sharma, 2011; Coleman et al., 2010; Lacaille-Dubois, 2007). 
Glycyrrhizin from licorice roots actively inhibits replication of severe acute respiratory syndrome (SARS) 
virus (Cinatl et al., 2003), and certain steroid saponins from T. terrestis are very active against 
fluconazole-resistant Candida species fungal pathogens (Zhang et al., 2005). In contrast to their 
stimulatory effect on specific immune responses, saponins have an inhibitory effect on inflammation, a 
non-specific immune reaction (Francis et al., 2002). Oral administration of AR-6, a triterpene saponin 
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isolated from Clematis chinensis Osbeck root, to rats with an induced rheumatoid-like arthritis resulted in 
a clear decrease of clinical signs of the disease (Sun et al., 2010). Saponins from various sources have 
been reported to prevent liver damage through a variety of mechanisms in vitro and in vivo (Lacaille-
Dubois, 2007). Oleanolic acid has even been used as an oral drug in China to treat acute and chronic 
hepatitis, as well as other liver disorders, by decreasing the occurrence of cirrhosis and returning elevated 
aminotransferase activity in the serum to normal levels (Liu, 1995). Saponins in crude mixtures and as 
purified compounds have been shown to have a variety of potentially therapeutic effects on the 
cardiovascular system. M. sativa aerial saponins were able to prevent atherosclerosis, the buildup of 
plaque in arteries, and induce regression of existing athersclerosis in rats (Bora and Sharma, 2011). The 
ginsenosides Rb1 and Re have been shown to inhibit contraction of ventricular myocytes from adult rat 
hearts in vitro by the stimulation of nitric oxide production, a property that could be used in the treatment 
of patients with hypertension (Scott et al., 2001; Sung et al., 2000). A mixture of saponins from Herniaria 
glabra decreased systolic and diastolic blood pressure in rats, while certain nonhemolytic steroidal 
saponins from Anemarrhena asphodeloides strongly inhibit platelet aggregation (Lacaille-Dubois, 2007). 
Saponins exhibit a variety of properties beneficial to human health that have led to the current and 
possible future use of saponins in medicine and are specific to saponin type and structure, including 
hypocholesterolemic, immunostimulatory, hypoglycemic, neuroprotective, anti-inflammatory, and 
hepatoprotective activities as well as therapeutic effects on the cardiovascular system and activity against 
viral, fungal, and bacterial human pathogens.  
Cytotoxicity of saponins 
 In addition to the previously described health benefits of saponins and most pertinent to this 
research, saponins from a variety of sources have been shown to have cytotoxic effects on many different 
cancer cell types in both in vitro and in vivo experiments. While the most obvious mechanism for these 
effects would seem to be membrane permeabilization, a non-specific process that would lead to 
inflammatory necrosis, this is fortunately not the case. Saponins without hemolytic activity have been 
shown to have cytotoxic activity (Mimaki et al., 1998), and a study of 63 different steroidal saponins found 
no correlation between hemolytic and cytotoxic activities (Wang et al., 2007). In addition, numerous 
studies of the cytotoxic activities of different triterpene and steroidal saponins identified a variety of 
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mechanisms besides membrane permeabilization (Bachran et al., 2008; Podolak et al., 2010; Weng et 
al., 2011). The most common and best studied effect of saponins on cancer cells is induction of 
apoptosis, or programmed cell death. Apoptosis can be initiated through either the extrinsic pathway, 
triggered at the plasma membrane by activation of specific receptors, or the intrinsic pathway, initiated 
within the cell in response to stress. In a recent review of the cytotoxic activity of saponins, there was only 
one example of the induction of the extrinsic pathway of apoptosis, by the saponin fraction from 
Bupleurum kaoi; instead, most saponins induce the intrinsic pathway of apoptosis through different 
mechanisms, including activation of p53 and various caspases, inhibition of the anti-apoptotic Bcl-2 
protein and activation of the pro-apoptotic Bax protein, induction of cytochrome c release, and 
mitochondrial membrane permeabilization (Bachran et al., 2008; Podolak et al., 2010). Avicin G isolated 
from Acacia victoriae (Bentham) induced apoptosis in the Jurkat human T cell leukemia cell line through 
activation of caspase-3 and initiation of cytochrome c release by direct action on the mitochondrial 
membrane (Haridas et al., 2001). Another common effect of saponins on cancer cells is cell cycle arrest 
through the downregulation of cyclin and cyclin dependent kinase (CDK) proteins and upregulation of 
CDK inhibitors (Bachran et al., 2008). The ginsenoside Rg3 has been shown to decrease proliferation of 
the LNCaP human prostate carcinoma cell line through activation of the expression of cyclin kinase 
inhibitors p21 and p27, arresting the cells in G1 phase (Liu et al., 2000). Other less frequent cytotoxic 
effects of saponins include initiation of autophagic cell death, when stressed cells break down their own 
contents to produce energy, inhibition of angiogenesis, cytoskeleton disintegration, and inhibition of 
metastasis (Podolak et al., 2010).  
 Saikosaponins, ginsenosides, soyasaponins, julibrosides, saikosaponins, dioscins, and avicins 
are among the most studied cytotoxic saponin groups, while oleanolic acid, the soyasapogenols, 
diosgenin, and betulinic acid are among the most studied cytotoxic sapogenins (Bachran et al., 2008; 
Güçlü-Üstündağ and Mazza, 2007). While it seems evident that saponin structure affects cytotoxic 
activity, there is not a sufficient amount of research to make generalizations about specific aspects of the 
structure-activity relationship (Weng et al., 2011). However, interesting studies do exist that begin to 
elucidate the structure-activity relationship in specific situations. In a study on the effects of various 
soyasaponins and soyasapogenols on the proliferation of HT-29 colon cancer cells, the more lipophilic 
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soyasapogenols were the most bioactive (Gurfinkel and Rao, 2003). These results were confirmed in a 
study by Salyer et al. (2013) that found that suppression of Caco-2 colon cancer cells intensified with the 
increasing lipophilicity of the two soyasaponins and one soyasapogenol tested. Gauthier et al. (2009) 
tested the cytotoxic activities of 31 natural and synthetic triterpene oleanane and lupane-type saponins 
and found that for oleanane-type saponins, an oleanolic acid backbone resulted in greater activity against 
A549 lung carcinoma cells in vitro than a hederagenin backbone. This finding was confirmed in a study by 
Bang et al. (2005), in which saponins with an oleanolic acid backbone showed more cytotoxic activity 
against four different cancer cell lines in vitro than saponins with hederagenin backbones. However, when 
the same saponins were used to treat BDF1 mice with Lewis lung carcinoma in vivo, saponins with 
hederagenin backbones had more potent antitumor activity than saponins with oleanolic acid backbones 
(Bang et al., 2005). This complicating lack of correlation between in vitro and in vivo data has been shown 
for multiple saponins and in this case could be due to differences in bioavailability (Podolak et al., 2010); 
Weng et al., 2011). A greater understanding of the relationship between saponin structure and cytotoxic 
activity would be useful in the synthetic modification of saponins to maximize their effects.  
 Whereas the majority of saponin cytotoxicity studies have been done in vitro, the number of in 
vivo studies, most of which are conducted in mice, is growing. Oral administration of playcodin D, purified 
from Platycodi radix, to athymic nude mice bearing H520 human lung cancer cells resulted in decreased 
tumor volumes and increased tumor cell apoptosis, as well as stimulation of the immune system and 
amelioration of cancer-related cachexia, or weakness (Park et al., 2014). Rhizoma paridis saponins 
delivered via intragastric administration to mice injected with mouse lung adenocarcinoma cells inhibited 
tumor growth by inducing apoptosis, downregulating levels of MMP-2 and MMP-9, and upregulating 
expression of the MMP inhibitor TIMP-2 (Man et al., 2009). Oral administration of deltonin from Dioscorea 
zingiberensis Wright to mice with C26 murine colon cancer resulted in inhibition of tumor growth through 
apoptosis induction and inhibition of angiogenesis (Tong et al., 2011). The safety and tolerability of 
individual saponins has not been extensively studied, but research on their effects in rodents and dogs 
generally suggests they are acceptably tolerable. In a subchronic toxicity study of the ginsenoside 
metabolite protopanaxadiol done for 90 days in beagles, the no observed adverse effect level (NOAEL) 
was 6.7 mg/day when given intravenously, which corresponds with high toxicological safety (Weng et al., 
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2011). As with their bioactivity, the safety of individual saponins is likely to vary based on their structure. 
The most obvious point of concern when considering the use of saponins as chemotherapeutic drugs is 
their hemolytic activity. It is important to note though that as mentioned earlier, some cytotoxic saponins 
do not have hemolytic properties, and even for some saponins that exhibit both properties the levels 
necessary for cytotoxic activity are lower than the levels necessary for hemolysis (Mimaki et al., 1998). As 
more is understood about the structure-activity relationship for both cytotoxicity and hemolytic activity, it 
may become feasible to modify highly cytotoxic saponins to abolish their hemolytic activity while keeping 
their cytotoxicity intact.  
 In addition to their possible use as individual chemotherapeutic agents, saponins could be used in 
combination with other cancer treatments to increase their efficacy. Various saponins have additive or 
even synergistic effects on the efficacy of other chemotherapeutic agents (Bachran et al., 2008). The 
ginsenoside Rh2 on its own had no effect on HRA human ovarian tumor growth in mice, but a 
combination of cisplatin and Rh2 prolonged survival of the mice significantly more than treatment of 
cisplatin or Rh2 alone, indicating synergistic effects (Kikuchi et al., 1991). Saponins may also play a role 
in the emerging field of targeted therapy, in which a toxin is attached to antibodies, cytokines, or growth 
factors that target the toxin to cancer cells, decreasing the negative side effects so common in non-
targeted chemotherapy (Thakur et al., 2013). In a study performed using HCT116 human colon 
carcinoma tumor-bearing mice, treatment with a combination of the plant ribosome-inactivating protein 
dianthin attached to epidermal growth factor and the saponin SO-1861 resulted in a greater than 95% 
tumor volume reduction (von Mallinckrodt et al., 2014). The synergistic effect of saponins on other 
chemotherapeutics and targeted toxins is likely due to effects on cellular transport processes that could 
facilitate more efficient delivery of these compounds to their cellular destination (Weng et al., 2011). 
Saponins from various plant sources have been shown to have cytotoxic activity against many different 
cancer cell types in vitro and in vivo through structure-specific targeting of various cellular processes and 
not through non-specific membrane permeabilization. They have also been shown to improve the efficacy 






 Legumes are grown on 180 million hectares or 12-15% of the earth’s arable land and make up 
27% of the world’s primary crop production, supplying 33% of the dietary protein nitrogen requirements of 
humans (Graham and Vance, 2003). Legumes are set apart from other plants by their ability to fix 
nitrogen from the environment, reducing N2 to NH3, through a symbiotic relationship with rhizobia bacteria 
in the soil that takes place in root nodules (Benedito et al., 2008). As a result, legumes do not require 
application of nitrogen fertilizer and can be used in crop rotation to increase soil nitrogen for use by other 
plants, leading to a decreased use of expensive and environmentally harmful nitrogen fertilizers. The 
primary dietary legumes include soybeans, peas, chickpeas, peanut, and lentils (Graham and Vance, 
2003). In addition to being sustainable sources of human protein, legumes are also used as forage for 
livestock, raw materials for industrial applications, and increasingly as natural sources of secondary 
metabolites (Choi et al., 2004b; Gholami et al., 2014). Medicago sativa, or alfalfa, is the most cultivated 
forage legume in the world and the fourth most economically valuable crop in North America, grown for 
soil improvement, animal forage, human food (as sprouts), and medicinal uses (Bora and Sharma, 2011; 
Gholami et al., 2014). Unfortunately, widely cultivated legumes in general, with their large, complex 
genomes, and alfalfa in particular, a tetraploid and obligate out-crosser, are not easily used in molecular 
genetic studies (Gholami et al., 2014; Tadege et al., 2005). In their place, Medicago truncatula, a close 
relative of alfalfa, has been widely studied as model legume due to its small diploid genome of about 500 
Mbp, self-fertilization and prolific nature, easy genetic transformation, and rapid generation time (Huhman 
and Sumner, 2002). Work in M. truncatula can be translated to the more economically valuable legume 
species due to genetic similarity; M. truncatula genes share very high sequence identity with 
corresponding alfalfa genes and seem to have similar chromosome placement as other legumes 
(Kapusta et al., 2005b).  
 The barrel medic, M. truncatula, originated in the Mediterranean basin, where diverse native 
populations can still be found in the wild, and has been cultivated in Australia as winter forage and in 
rotation with wheat for the last century (Choi et al., 2004a). In addition to the natural traits that make it an 
attractive model, the scientific community has developed many tools to facilitate genetic studies of M. 
truncatula, including a fully sequenced genome, almost 270,000 expressed sequence tags (ESTs) in 
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Genbank, a metabolic pathway map called MedicCyc, and a collection of mutants produced by various 
methods, including the use of the Tnt1 tobacco retrotransposon (Gholami et al., 2014; Tadege et al., 
2005). Genetic maps of molecular markers based on anonymous sequence polymorphisms (Thoquet et 
al., 2002) and sequence-characterized loci have been created (Choi et al., 2004a), as well as a 
comprehensive gene expression atlas with information on all the major organ systems and multiple 
stages of seed and nodule development (Benedito et al., 2008). For all the genetic work done in M. 
truncatula, the biological activity of its saponins towards cancer cells has not previously been studied 
(Podolak et al., 2010). Four genetically distinct accessions of M. truncatula that vary in the level and types 
of saponins produced were used in this project, A17, ESP105, PRT178, and GRC43. All are single seed 
descent lines chosen from a collection of 145 geographically diverse populations sampled primarily from 
the western part of the Mediterranean basin and maintained by the Institut National de la recherché 
Agronomique (INRA) in France (Delalande et al., 2007). A17, the primary focus of previous genetic 
research, is derived from Jemalong, a commercial variety of M. truncatula, and reflects the efforts of 
selective breeding, while the other three accessions, ESP105, PRT178, and GRC43, were isolated from 
the wild in Spain, Portugal, and Greece, respectively, and reflect adaptation to the selective pressures of 
their unique environments. Legumes are economically important due to their ability to fix nitrogen and 
serve as a sustainable source of protein for humans and livestock, and M. truncatula is widely used as a 
model legume in scientific research. The availability of genetically distinct accessions with varying levels 
of saponin accumulation and the genetic tools that have been developed for M. truncatula make it an 
ideal organism for research on saponin biosynthesis.  
Triterpene saponin biosynthesis in M. truncatula 
 More than 30 triterpene saponins have been detected in M. truncatula (Huhman and Sumner, 
2002). As previously described, triterpene saponin synthesis originates in the MVA pathway with the 
conversion of acetyl-CoA into IPP and DMAPP, which then condense to form FPP. Two FPP molecules 
condense to form squalene, which is then epoxidized to form 2,3-oxidosqualene (Moses et al., 2014a). 3-
hydroxy-3methylglutarylcoenzyme A reductase (HMGR) is the key rate-limiting enzyme in the MVA 
pathway. Five isoforms of HMGR have been characterized in M. truncatula, and HMGR gene expression 
is induced by methyl jasmonate in a pattern similar to other triterpene saponin synthesis genes in M. 
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truncatula (Kevei et al., 2007; Pollier et al., 2013). One squalene synthase and two squalene epoxidase 
gene candidates were identified in the M. truncatula genome by comprehensive gene expression 
clustering analysis (Naoumkina et al., 2010) and then functionally characterized by expression in 
Escherichia coli and complementation of the yeast erg1 mutant, respectively (Suzuki et al., 2002). In M. 
truncatula the first committed step in triterpene saponin synthesis is the cyclization of the linear 2,3-
oxidosqualene by β-amyrin synthase to form β-amyrin. All saponins in M. truncatula are based on the 
modification of β-amyrin and have pentacyclic oleanane-type sapogenin backbones with a double bond 
between C-12 and C-13 and an oxygen at the C-3 position (Gholami et al., 2014). The β-amyrin synthase 
gene has been characterized by expression in yeast by two separate research groups (Iturbe-Ormaetxe 
et al., 2003; Suzuki et al., 2002). An alternate fate for 2,3-oxidosqualene is synthesis of cycloartenol, the 
tetracyclic plant sterol precursor, by cycloartenol synthase (Gholami et al., 2014).  
 After formation of β-amyrin, the synthesis pathway branches to create two distinct classes of 
triterpene saponins, hemolytic and non-hemolytic. The non-hemolytic sapogenins (soysapogenol A, B, 
and E) are characterized by oxidation at the C-24 position that is compatible with modifications at the C-
21 and C-22 positions, while the hemolytic sapogenins (oleanolic acid, hederagenin, bayogenin, 
medicagenic acid, and zanhic acid) are characterized by a carboxyl group at the C-28 position that is 
compatible with C-23 modification but prohibits C-24 modification (Moses et al., 2014c). In non-hemolytic 
saponin synthesis, CYP93E2 carries out the hydroxylation at C-24, which is followed by oxidation at the 
C-22 position catalyzed by CYP72A61v2 (Fukushima et al., 2013). This yields soyasapogenol B which 
can then be further modified to form soyasapogenol A, characterized by oxidation at the C-21 position, or 
soysapogenol E, characterized by further oxidation at the C-22 position. The enzymes responsible for 
these conversions have not yet been identified in M. truncatula (Gholami et al., 2014). In hemolytic 
saponin synthesis, CYP716A12 catalyzes three consecutive oxidations at the C-28 position of β-amyrin to 
yield oleanolic acid (Carelli et al., 2011; Fukushima et al., 2011). Carelli et al. (2011) showed that lha 
(lacking hemolytic activity) mutant plants with disrupted CYP716A12 genes were unable to produce 
hemolytic saponins, synthesizing only soysaponins. Oleanolic acid can then be converted into alternate 
hemolytic sapogenin backbones through a series of sequential reactions catalyzed by cytochrome P450 
enzymes. CYP72A68 expressed in yeast in combination with CYP716A12 exhibited oxidation activity at 
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the C-23 position of oleanolic acid but was unable to oxidize β-amyrin when expressed in yeast alone 
(Fukushima et al., 2013). Two CYP72A68 isoforms were identified in the M. truncatula genome by Biazzi 
et al. (2015) and shown to preferentially transform substrates that had previously been oxidized at the C-2 
position (2β-hydroxy oleanolic acid and bayogenin) over substrates lacking C-2 oxidation (hederagenin 
and oleanolic acid). CYP72A67 expressed in yeast was shown to catalyze this C-2 oxidation and to do so 
most efficiently when the substrate lacked C-23 and C-16 oxidation (Biazzi et al., 2015). Zanhic acid, a 
sapogenin detected in M. truncatula, is oxidized at the C-16 position, in addition to the C-23 and C-2 
position. The enzyme responsible for this oxidation has not yet been identified in M. truncatula. However, 
CYP87D16 and CYP716Y1 have been shown to have C-16 oxidase activity in triterpene saponin 
synthesis in Maesa lanceolata and Bupleurum falcatum, respectively (Moses et al., 2014b; Moses et al., 
2015). This data, especially the recent Biazzi et al. (2015) study, was collectively used to construct the 
hypothetical M. truncatula sapogenin biosynthesis pathway depicted in Figure 2.  
 
	  
Figure 2. Saponin aglycone biosynthesis in M. truncatula. Hypothetical pathway shown is according to 
Biazzi et al. (2015). 
 
Once oxidative modification of the sapogenin backbone is complete, it is glycosylated at different 
positions with varying sugar moieties by UDP-dependent glycosyltransferases (UGTs) that are still largely 
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unknown. In Medicago species, glycosylation usually occurs at the C-3 hydroxy and C-28 carboxy 
groups, and the attached sugar chains have been reported to include glucose, rhamnose, xylose, 
glucuronic acid, galactose, and arabinose (Gholami et al., 2014). UGT73K1 and UGT71G1 have been 
functionally characterized as UDP-dependent glucosyltransferases active in M. truncatula saponin 
synthesis with specificity for hederagenin, and soyasapogenols B and E (UGT73K1) and medicagenic 
acid (UGT71G1) (Achnine et al., 2005). Plants with a UGT73F3 loss-of-function mutation were found to 
have decreased levels of glycosylated saponins derived from hederagenin, bayogenin, medicagenic acid, 
and soyasapogenol E backbones (Naoumkina et al., 2010).  
The differential accumulation of varying saponin mixtures across plant tissues and in response to 
herbivory suggests the existence of specific regulators of saponin biosynthesis. Stress-induced saponin 
biosynthesis is mediated by concerted transcriptional activation of synthesis genes controlled by a 
complex signaling cascade involving jasmonates (JAs), oxylipin-derived phytohormones that control a 
variety of plant physiological processes (De Geyter et al., 2012; Gholami et al., 2014; Mertens et al., 
2016). M. truncatula cell culture suspensions exposed to methyl jasmonate show a 50-fold induction of β-
amyrin transcripts and increased synthesis of over 30 different triterpene saponins (Broeckling et al., 
2005; Suzuki et al., 2004). By looking at the transcriptome of M. truncatula suspension-cultured cells after 
elicitation with JAs, Pollier et al. (2013) were able to identify the RING E3 ubiquitin ligase makibishi 1 
(Mkb1) gene, which encodes a protein involved in the endoplasmic-reticulum-associated degradation 
(ERAD) quality control system, as being transcriptionally upregulated before similar upregulation of 
saponin synthesis genes. MKB1 manages saponin synthesis by targeting HMGR, the rate-limiting 
enzyme in the MVA pathway, for degradation by the 26S proteasome, and prevents unrestrained 
bioactive saponin accumulation that could threaten plant development and integrity (Pollier et al., 2013). 
Until very recently nothing was known about transcription factors that might mediate the effect that 
jasmonate signaling has on regulation of saponin biosynthesis. Two JA-inducible transcription factors 
from the basic helix-loop-helix family, TSAR1 and TSAR2 have recently been shown to transactivate the 
genes encoding HMGR1 and MKB1, as well as other downstream saponin biosynthesis genes. 
Overexpression of TSAR1 and TSAR2 in M. truncatula hairy roots results in increased transcript levels of 
saponin biosynthesis genes and saponin accumulation, with TSAR1 overexpression specifically 
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increasing nonhemolytic saponin biosynthesis and TSAR2 overexpression specifically increasing 
hemolytic saponin biosynthesis (Mertens et al., 2016). Saponin synthesis originates in the mevalonate 
pathway, and production of β-amyrin is the first commited step. Cytochrome P450 enzymes catalyze 
various oxidative modifications of β-amyrin to form several chemically distinct sapogenins belonging to 
two groups, non-hemolytic soyasaponins and hemolytic saponins. Saccharide sugar chains are then 
attached to sapogenins by UDP-dependent glycosyltransferases. While many of the genes encoding 
enzymes in the early stages of saponin synthesis have been identified, there is still much to be 
discovered, including the genes encoding most of the UDP-dependent glycosyltransferases and the 
mechanisms of saponin biosynthesis regulation.  
Caco-2 cell culture 
 The Caco-2 cell culture line was originally derived from colorectal adenocarcinoma cells obtained 
from a primary tumor in the colon of a 72-year-old Caucasian male (Lindl and Steubing, 2013). Upon 
reaching confluence in culture, Caco-2 cells undergo a spontaneous differentiation pathway and begin to 
express many characteristics of small intestine enterocytes (Sambuy et al., 2005). As a result, Caco-2 
monolayers are frequently used in research as an in vitro model for intestinal drug absorption (Artursson 
and Karlsson, 1991). Caco-2 cells form moderately well differentiated adenocarcinoma tumors that 
resemble primary colonic tumors when injected in nude mice and can be used in cell culture to test the 
cytotoxicity of certain compounds against colon cancer cells if they are not permitted to grow to 
confluence and differentiate (Lindl and Steubing, 2013). Saponins from Gaultheria trichophylla, 
Pleiocarpa pycnantha, and Glycine max have all been shown to inhibit Caco-2 cell proliferation (Alam et 
al., 2015; Omoyeni et al., 2015; Salyer et al., 2013). Colorectal cancer is the third most common cancer 
and the third leading cause of cancer death for both men and women in the United States and among the 
most common cancers worldwide (Omoyeni et al., 2015). Colorectal cancer risk increases with age, with 
90% of new cases and 94% of deaths occurring in people over 50 years of age (von Mallinckrodt et al., 
2014). Surgical removal is the preferred treatment for localized disease, but many colorectal cancer 
patients have metastasis by the time they are diagnosed. Treatment in this situation is mainly based on 5-
fluorouracil and folinate chemotherapy in combination with radiotherapy. However, standard treatment 
protocols result in only a moderate decline in mortality, and risk of disease recurrence remains high (Tong 
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et al., 2011). Caco-2 cells grown in culture will be used to study the effects M. truncatula saponins on cell 
proliferation and apoptosis induction in human colon cancer cells.  
Concluding statements 
 When attacked by pathogens, plants defend themselves by specialized metabolism of a broad 
range of compounds with varied biological activities that can be exploited by humans to solve many of the 
problems our world faces today. Saponins are a chemically diverse family of specialized metabolites 
whose amphipathic character and complex structure imparts them with many properties that have led to 
their current and possible future use in industry, agriculture, and the improvement of human health. 
Among these properties is the cytotoxic activity saponins from various plant sources have been shown to 
exercise against different cancer cell types in vitro and in vivo through structure-specific targeting of 
various cellular processes. More complete knowledge of the genetic basis for saponin biosynthesis could 
lead to more extensive utilization of these beneficial compounds, and investigation of the effects of 
previously untested saponins on cancer cells could add to our understanding of their cytotoxic activity and 
lead to the development of novel chemotherapeutic drugs. The natural variation in saponin accumulation 
among genetically distinct accessions of the model legume M. truncatula and the genetic tools associated 







Crosses between M. truncatula accessions with divergent levels of saponin accumulation will 
produce populations with large variation in saponin content that can be used to identify the genetic 
components controlling saponin synthesis, and saponin extracts from M. truncatula accessions with 
diverse saponin profiles will demonstrate varying levels of cytotoxic activity against Caco-2 cells grown in 
culture.  
Objective 1 
Compare the CYP72A68 cDNA sequences of M. truncatula accessions to examine accession 
differences in protein functionality and identify single nucleotide polymorphisms that can be used to 
develop accession-specific molecular markers for confirmation of putative crosses.  
Objective 2 
Quantify accumulation of hemolytic saponins and expression of genes encoding hemolytic 
saponin synthesis enzymes in foliar tissue of a M. truncatula population to determine the pattern of 
inheritance of saponin accumulation traits and investigate the mechanisms regulating saponin synthesis.  
Objective 3 
Analyze crude saponin extracts from foliar tissue of M. truncatula accessions by HPLC mass 
spectrometry to quantify total saponins for treatment of cell cultures with accurate and equal 
concentrations of saponins across the accessions and identify individual saponins that may contribute to 
cytotoxic activity.  
Objective 4 
Evaluate Caco-2 cell proliferation and apoptosis induction after treatment with M. truncatula 
saponin extracts to determine the differential effects of accessions extracts on colon cancer cell growth 





Genetic basis for triterpene saponin biosynthesis in Medicago truncatula 
 
Introduction 
 Saponins are a family of specialized metabolites produced by a variety of plants that are believed 
to play a role in plant defense due to their biological activity against many plant pathogens and the ability 
of jasmonates to elicit their production (Gholami et al., 2014). Saponins are composed of a hydrophobic 
isoprene-derived aglycone, often called a sapogenin, and a polar sugar moiety. The presence of both 
components makes saponins amphiphilic, which allows them to create stable foams in aqueous solution, 
the trait for which they were named; saponin comes sapo, the Latin word for soap. There are two types of 
saponins, steroidal saponins, which have a 27-carbon aglycone, and triterpene saponins, which have a 
30-carbon aglycone (Weng et al., 2011). The saponin polar sugar moiety is made up of saccharide side 
chains containing varying numbers and types of sugar constituents, and saponins can be further 
classified as mono-, bi-, or tri-desmoside depending on the number of saccharide side chains that are 
attached to the aglycone (Francis et al., 2002). Saponins are currently used in industry as additives in 
food and cosmetics due to their ability to act as emulsifying, foaming, and flavoring agents and are 
utilized in the removal of cholesterol from dairy products. In agriculture, there is growing interest in 
replacing synthetic chemicals used in crop protection and antibiotics used as livestock feed additives with 
saponins. Many saponins have been shown to have insecticidal, nematicidal, allelopathic, fungicidal, 
antibacterial, and antiviral properties that allow them to protect the plants that produce them from 
pathogen attack (Augustin et al., 2011). Finally, saponins exhibit a variety of properties that could be 
useful in the improvement of human health, including hypocholesterolemic, hypoglycemic, 
hepatoprotective, immunostimulatory, anti-inflammatory, and anticancer properties (Lacaille-Dubois, 
2007). Unfortunately, the large-scale commercial and medicinal use of saponins is limited by the relatively 
low levels of saponins produced in nature and the expense associated with chemical synthesis of such 
complex molecules (Misawa, 2011). Engineering of the saponin synthesis pathway to increase production 
in plants that endogenously produce saponins and plants that lack saponin production could result in 
higher yields of commercially and medicinally important saponins and allow for additional pest protection 
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of economically important crops. However, pathway engineering for increased production of saponins is 
not yet possible due to gaps in our knowledge of the genetic basis for saponin biosynthesis (Gholami et 
al., 2014; Misawa, 2011). 
 The annual legume M. truncatula is a close relative of alfalfa grown as winter forage in Australia 
and is often used in research to study root nodulation and specialized metabolism due to natural 
characteristics that make it easy to work with and several tools developed by the scientific community that 
facilitate genetic studies (Choi et al., 2004a; Huhman and Sumner, 2002). Saponin synthesis in M. 
truncatula is restricted to triterpene saponins, of which two types are produced, non-hemolytic 
soyasaponins and hemolytic saponins. Synthesis originates in the mevalonate pathway with the 
production of IPP, which combines with DMAPP to form FPP. Two FPP molecules condense to form 
squalene, which is epoxidized to form 2,3-oxidosqualene that is cyclized to produce β-amyrin. This serves 
as the branchpoint between the two types of saponin synthesis present in M. truncatula as β-amyrin can 
be funneled into the production of soyasapogenol B or oleanolic acid. Cytochrome P450 enzymes 
catalyze the oxidative modification of soyasapogenol B and oleanolic acid to produce the full range of 
non-hemolytic and hemolytic sapogenins, respectively. Glycosyltransferases are responsible for attaching 
saccharide sugar chains to the sapogenins to yield the completed saponin product (Gholami et al., 2014). 
Many of the genes encoding enzymes responsible for the various steps of saponin synthesis in M. 
truncatula have been identified and functionally characterized by heterologous expression in microbial 
systems. Concerning the early steps of saponin synthesis, five isoforms of HMGR, the rate-limiting 
enzyme in the mevalonate pathway, a squalene synthase gene, and two isoforms of squalene epoxidase 
have been characterized (Kevei et al., 2007; Suzuki et al., 2002). The enzyme β-amyrin synthase is 
responsible for cyclization of 2,3-oxidosqualene into β-amyrin, the first committed step in triterpene 
saponin synthesis (Iturbe-Ormaetxe et al., 2003; Suzuki et al., 2002). In the non-hemolytic soyasapogenol 
synthesis pathway, CYP93E2 and CYP72A61v2 have been characterized as the enzymes responsible for 
conversion of β-amyrin into soyasapogenol B by catalyzing oxidation at the C-24 and C-22 positions, 
respectively (Fukushima et al., 2013). The enzymes responsible for further oxidation of soyasapogenol B 
at the C-22 position to form soyasapogenol E and oxidation of soyasapogenol B at the C-21 position to 
form soyasapogenol A have not been identified. In the hemolytic sapogenin synthesis pathway, 
	  
 26	  
CYP716A12 has been characterized as the enzyme catalyzing the conversion of β-amyrin into oleanolic 
acid via three consecutive oxidations at the C-28 position (Carelli et al., 2011; Fukushima et al., 2011). 
Oleanolic acid is then converted into alternate sapogenins through a series of sequential reactions 
catalyzed by CYP72A67, a C-2 oxidase, and CYP72A68, a C-23 oxidase (Biazzi et al., 2015; Fukushima 
et al., 2013). The enzyme responsible for the final reaction in the series, the oxidation of medicagenic 
acid at the C-16 position to form zanhic acid, has not yet been identified. Of the many 
glycosyltransferases likely to be active in M. truncatula, only three have been functionally characterized, 
UGT73K1, UGT71G1, and UGT73F3 (Achnine et al., 2005; Naoumkina et al., 2010). The factors 
regulating saponin synthesis in M. truncatula are still largely unknown. A RING E3 ubiquitin ligase Mkb1 
involved in posttranscriptional regulation of HMGR and two transcription factors TSAR1 and TSAR2 
controlling expression of genes encoding enzymes along the entire saponin synthsis pathway have been 
identified in M. truncatula hairy roots (Mertens et al., 2016; Pollier et al., 2013).  
 The M. truncatula species is made up of many genetically distinct accessions, some of which 
have been isolated from the wild while others originate from selective breeding programs. Three single-
seed descent accessions that vary in the levels and types of saponins they accumulate were chosen for 
this research. A17, derived from a commercial variety of M. truncatula, and PRT178, isolated from the 
wild in Portugal, produce relatively high levels of saponins in their foliar tissue compared to ESP105, an 
accession isolated from the wild in Spain (Lloyd Sumner, unpublished data). Separate crosses were 
made between the low saponin producing ESP105 accession and each of the high saponin producing 
accessions, A17 and PRT178, to produce populations that were used to study the pattern of inheritance 
of foliar saponin accumulation. Expression of genes encoding enzymes involved in late steps of hemolytic 
saponin synthesis was also analyzed in the foliar tissue of cross progeny. The CYP72A68 cDNA from the 
three accessions was sequenced and compared to generate SNPs for confirmation of crosses and to 





Materials and Methods 
Plant maintenance 
 For plants used in crossing, M. truncatula seeds from the A17, ESP105, and PRT178 accessions 
were removed from seedpods and scarified for 5 min in a small volume (<1 ml) of 18 M sulfuric acid. 
Scarified seeds were then vernalized to induce early flowering by germinating on 0.8% water agar in Petri 
plates wrapped in foil in a 4°C cooler for 10 days. Successfully germinated seedlings were planted in 
Sunshine LC1 mix potting medium (SunGro Horticulture Distribution Inc., Bellevue, WA) and grown in a 
growth chamber with a 25°C daytime and a 21°C nighttime temperature and 60% humidity with a 16:8 
(light:dark) hour photoperiod as recommended in the Medicago truncatula Handbook (Barker et al., 
2007). Plants were watered when the top layer of the potting medium had dried, approximately every 
three days. Plants were fertilized weekly using Miracle-Gro© water-soluble tomato plant food (N-P-K ratio 
18-18-21) (Scotts Miracle-Gro Products, Inc., Marysville, OH) at a rate of 15 g per 3.78 liters (1 gallon), 
and treated biweekly with a biological larvicide (Gnatrol© WDG, Valent BioSciences Corporation, 
Libertyville, IL) at a rate of 1.7 g per 3.78 liters. Transplantation to larger pots occurred as needed. Seed 
pods resulting from self-fertilization were removed regularly to maintain full-flowering potential. 
 Seed of F1 and F2 generation was scarified and germinated between two layers of moistened filter 
paper in a closed container. The container was placed in a dark cabinet for four days to allow for 
germination. Resulting plants were maintained in a growth chamber at 22.5°C and 60% humidity with a 
16:8 (light:dark) hour photoperiod. Once presence of male parent DNA was confirmed in putative 
progeny, clonal cuttings were made from F1 plants to increase seed production. Using a sharp razor 
blade, a cut was made at a 45° angle below the youngest node of a healthy branch. The tip was 
immediately placed in a beaker of water for approximately 3 s to prevent xylem cavitation and then dipped 
in Hormex Rooting Powder No. 3 (Brooker Chemical, Chatworth, CA) before planting in Sunshine LC1 
mix potting medium (SunGro Horticulture Distribution Inc., Bellevue, WA) in a tray covered with a dome to 
maintain high humidity. When seed pods were near maturity, original plants and cuttings were moved to a 
greenhouse, staked up, and wrapped in perforated plastic to allow for the collection of seedpods as they 





Crosses in M. truncatula were performed as described by Veerappan et al. (2014). On the female 
parent plant, an unopened flower with immature pollen was cut along the outer edge of the keel petal 
using a sharp scalpel. The standard and keel petal were then pushed back and forceps were used to 
remove the immature anthers, taking care not to disrupt anthers and stimulate pollen release. An 
unopened flower with mature pollen was then removed from the male parent plant. Using forceps, all 
petals were removed to expose the pollen-loaded anthers and the pollen was deposited on the stigma of 
the first flower. When possible, three flowers from the male parent plant were used to ensure an excess 
of pollen was deposited. The standard and keel were then repositioned and rubbed closed on the 
emasculated flower, and the flower was wrapped in plastic cling wrap for 2 days to create a humid 
environment that would discourage desiccation of internal organs. Seedpods from successful crosses 
were wrapped in perforated plastic wrap and collected when they naturally detached from the plant.  
 
RNA extraction 
  Extraction of RNA for sequencing of CYP72A68 cDNA was performed according to the 
manufacturer’s instruction using TRI Reagent® (Molecular Research Center, Inc. Cincinnati, OH). Roots 
from A17, ESP105, and PRT178 plants grown in a hydroponic system were collected into foil packets and 
immediately submerged in liquid nitrogen. Approximately 100 mg of root tissue were ground to a fine 
powder in liquid nitrogen using a mortar and pestle and transferred to a 2 ml tube with 1 ml of TRI 
Reagent®. After 5 min incubation at room temperature, 100 µl of bromochloropropane were added. 
Samples were mixed vigorously, incubated for 10 min at room temperature, and centrifuged at 12,000 g 
and 4°C for 15 min. The aqueous phase of each sample was then transferred to a fresh 1.5 ml tube and 
mixed by tube inversion with 250 µl isopropanol and 250 µl of a high salt solution to precipitate RNA. 
Samples were incubated at room temperature for 7 min and centrifuged at 12,000 g and 4°C for 7 min. 
The resulting pellets were washed with 1 ml 75% ethanol, centrifuged at 7,500 g and 4°C for 5 min, and 
air-dried. The pellet was dissolved in diethylpyrocarbonate-treated water and quantified using the 
BioSpec-nano™ spectrophotometer (Shimadzu Scientific Instruments, Kyoto, Japan). 
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 RNA used in qPCR was extracted using the Qiagen RNeasy® Plant Mini Kit (Qiagen, Hilden, 
Germany). Trifoliates were wounded using a hemostat to damage each leaflet 3.5 hours before tissue 
collection. Three trifoliates were collected per replicate into a foil packet and immediately submerged in 
liquid nitrogen. Three replicates were collected per experimental condition (A17, ESP105, and 
A17xESP105 F2 plants with high, medium, or low hemolysis) with each replicate consisting of an 
individual plant. Trifoliates were ground to a fine powder in liquid nitrogen using a mortar and pestle and 
transferred to a 1.5 ml tube of lysis buffer with β-mercaptoethanol. The lysate was then centrifuged 
through a QIAshredder homogenizing column. Ethanol was added to the supernatant of the flow-through, 
and the sample was loaded onto an RNeasy mini spin column. Once the RNA had bound to the silica-
based column membrane, contaminants were removed in three separate washes. The RNA was then 
eluted using RNase-free water and quantified using the BioSpec-nano™ spectrophotometer (Shimadzu 
Scientific Instruments, Kyoto, Japan). 
 All cDNA was synthesized using the iScript™ cDNA Synthesis Kit (Bio-Rad Laboratories, Inc.). 
RNA template (1 µg) was combined with reaction buffer, reverse transcriptase, and nuclease-free water, 
and the reaction was run on a PTC-100™ Programmable Thermal Controller (MJ Research, Inc.) 
following a program of 25°C for 5 min, 42°C for 30 min, and 85°C for 5 min.  
 
Sequencing 
 The CYP72A68 root cDNA was amplified through PCR using primers based on the known 
sequence of A17 CYP72A68 cDNA. PCR with 25 µl reaction volumes were carried out using 10X Taq 
buffer (GenScript), Taq DNA polymerase (5 U/µl, GenScript), and 1 µl cDNA template diluted 1:5 in water. 
The final concentrations of the dNTPs were 0.2 mM, and the final concentrations of the forward and 
reverse primers were 1.2 µM. PCR product was purified using the GeneJET™ PCR Purification Kit 
(Fermentas Life Sciences) and quantified using the BioSpec-nano™ spectrophotometer (Shimadzu 
Scientific Instruments, Kyoto, Japan). cDNA template (40 ng) was combined with 3.4 pmol primer and 
brought up to 13 µl total volume with water. Samples were then sent to the University of Arkansas DNA 
Resource Center for sequencing. Obtained sequences were aligned using the CLUSTAL W multiple 
sequence alignment tool (Higgins et al., 1992; Thompson et al., 1994) and translated using the 
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SIXFRAME tool made available through the San Diego Supercomputer Center (SDSC) Biology 
Workbench. Translated CYP72A68 sequences and CYP72A protein sequences from other plant species 
(GenBank accession numbers in Table 1) were aligned using CLUSTAL W and a rooted phylogenetic 
tree was created with PHYLIP (Felsenstein, 1989). M. truncatula CYP72A68 and legume CYP72A protein 
sequences were aligned and highlighted using the Multiple Align Show tool made available on the 
Sequence Manipulation Suite online (Stothard, 2000).  
 
Table 1. GenBank accession numbers for plant CYP72A proteins 
Species Annotation Accession No. 
Arabidopsis thaliana CYP72A15 OAD04430.1 
Arachis duranensis CYP72A15-like XP_015932338.1 
Cajanus cajan CYP72A1-like KYP48914.1 
Catharanthus roseus CYP72A1 Q05047.1 
Cicer arietinum CYP72A219-like XP_004488665.1 
Glycine max CYP72A219-like XP_003546751.1 
Glycyrrhiza uralensis CYP72A154 H1A988.1 
Medicago truncatula (A17) CYP72A68 ABC59077.1 
Morus notabilus CYP72A1-like XP_010092742.1 
Oryza sativa CYP72A15-like XP_015615867.1 
Panax ginseng CYP72A219 H2DH21.1 
Vitus vinifera CYP72A219-like XP_003634773.1 




 DNA was extracted using the Qiagen DNeasy® Plant Mini Kit (Qiagen, Hilden, Germany). Young 
trifoliates were collected on ice and used immediately for extraction. Approximately 100 mg tissue, or 3-4 
trifoliates, was disrupted in lysis buffer containing RNase A stock solution using a small plastic pestle 
powered by a drill. After incubation at 65°C, proteins and polysaccharides were precipitated from the 
lysate using a salt solution. The precipitates and additional cell debris were then removed from the lysate 
by filtration through a QIAshredder Mini spin column. Binding buffer and ethanol were added to the lysate 
and the sample was applied to a DNeasy Mini spin column. After binding to the column membrane, the 
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DNA was washed twice to remove remaining contaminants and then eluted with 50 µl of a low-salt elution 
buffer. DNA was quantified using the BioSpec-nano™ spectrophotometer (Shimadzu Scientific 
Instruments, Kyoto, Japan). 
 
Confirmation of crosses 
 PCR reactions with 25 µl reaction volumes were carried out using 10X Taq buffer (GenScript), 
Taq DNA polymerase (5 U/µl, GenScript), and 1 µl undiluted DNA template (8-24 ng). The final 
concentrations of the dNTPs were 0.2 mM, and the final concentrations of the forward and reverse 
primers were 1.2 µM. Amplification of actin was performed simultaneously to confirm DNA was present 
and able to be amplified. A Hybaid PCR Express thermal cycler was used to run the reactions. Different 
primer sets required specific annealing temperatures to ensure stringent amplification (Table 2), so the 
reactions were run using 1 cycle of 95°C for 2 min; 30 cycles of 95°C for 30 s, varying temperatures for 
30 s, and 72°C for 30 s; and 1 cycle of 72°C for 5 min. Actin amplification was performed using an 
annealing temperature of 55°C. Electrophoresis of PCR products was performed on 1% agarose gels 
using GelGreen (Biotium, Hayward, CA). DNA was visualized with a FluorChem™ 8800 gel 
documentation system (Alpha Innotech Corporation). 
  
Table 2. Annealing temperatures for primers used in cross confirmation 
Primer 
Name 
Cross Tested Annealing 
Temperature (°C) 
Sequence 
AxE_For A17 x ESP105 58 5’-TGCTCCTTACATTCATCAC 
AxE_Rev A17 x ESP105 58 5’-AAGTCATTCTCAGTGGCA 
ExP_For ESP105 x PRT178 63.4 5’-GGGGTTTCAAAACTGGACAGTG 
ExP_Rev ESP105 x PRT178 63.4 5’-GCCGGAACCTATGCTGA 
PxE_For PRT178 x ESP105 66.6 5’-GGCAATGGCATTGATTTTAC 
PxE_Rev PRT178 x ESP105 66.6 5’-GATGACATACGTTTCTTCTCTGA 
 
 
Saponin hemolysis assay 
 Plants used for the screening of A17 x ESP105 F2 progeny were 4- to 7-weeks old.  A handheld 
plant sap press (Spectrum Technologies, Inc., Aurora, IL) was used to extract juices from five trifoliates 
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per plant. Leaf juices were kept on ice throughout the extraction process. Wells of approximately 3 mm 
diameter were made in blood agar plates (5% sheep blood in tryptic soy agar, BioMerieux Inc., Durham, 
SC for A17 x ESP105 F1 and Hardy Diagnostics, Santa Maria, CA for all others) using TipOne 
micropipette filter tips (1-200 µl, USA Scientific, Inc., Ocala, FL) that had been cut at the second line from 
the bottom of the tip and sterilized. Leaf extract (15 µl) was added to each well. Each plate contained 6 
wells loaded with parent accession leaf juices, 3 per parent, as a control between plates and a standard 
for analyzing sample hemolysis. Plates were placed in a closed plastic container with a damp paper towel 
and left to incubate in a dark place at room temperature for approximately 4.5 hours or overnight.  
 To quantify the hemolysis observed for the 141 A17 x ESP105 F2 plants, Microsoft Powerpoint 
was used to measure the diameter of clearing zones, including the well diameter. For each plate, the 
diameters of the three ESP105 wells were averaged. Then, the diameters for the A17 and F2 clearing 
zones on the same plate were divided by this number to account for differences in picture size among 
plates. This ratio was called d/ESP. The d/ESP ratios for all the A17 clearing zones across all plates 
(n=24) were averaged and the standard deviation was calculated. The A17 d/ESP average minus the A17 
d/ESP standard deviation served as the lower limit for the classification of the high hemolysis phenotype. 
Any F2 plant with a d/ESP ratio lower than the high classification limit that had visible hemolysis was 
classified as medium. F2 plants with no visible hemolysis were classified as low.  
 
Gene expression studies using qPCR 
 Real-time PCR was performed using the Applied Biosystems StepOnePlus™ real time PCR 
systems. RNA extracted using the Qiagen RNeasy® Plant Mini Kit was used to synthesize cDNA using 
iScript™ cDNA Synthesis Kit (Bio-Rad Laboratories, Inc.) as described previously. The cDNA was diluted 
1:5 in water and 1 µl was added to 10 µl of Power SYBR® Green PCR master mix (Applied Biosystems) 
mixed with 0.27 µl each forward and reverse primers (15 µM) and 8.47 µl water, for a total reaction 
volume of 20 µl. Three technical and biological replicates were run for each sample using the following 
cycling protocol: 95°C for 10 min followed by 40 cycles of 95°C for 15 s and 56°C for 1 min.  
Equation 1: ΔCt = Cttarget - Ctreference 
target = gene of interest; reference = reference housekeeping gene 
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Equation 2: ΔΔCt = ΔCtexperimental - ΔCtcontrol 
experimental = A17 or F2 phenotype; control = ESP105 
Equation 3: Fold Change = 2-ΔΔCt 
Gene expression ratios for each gene were calculated using the 2-ΔΔCt method described by Livak 
and Schmittgen (2001). The average Ct was calculated for each biological replication (e.g. A17 1, A17 2, 
A17 3, ESP105 1, etc.). Actin was used as the reference housekeeping gene. The average Ct values for 
the target and reference gene of the same biological replication were used in equation 1 to generate a 
ΔCt value for each biological replication. An average ΔCt was calculated for the ESP105 biological 
replications, arbitrarily chosen as the control due to its generally low levels of saponin synthesis gene 
expression. The ΔCt for each biological replication was used as the experimental value and, the average 
ESP105 ΔCt was used as the control value in equation 2 to generate a ΔΔCt value for each biological 
replication. This value was then used in equation 3 to generate a fold change for each biological 
replication. The average and standard deviation of the fold change values for the three biological 
replications per biological group were then calculated.  
 
Statistical analysis 
 GraphPad Prism (GraphPad Software Inc., La Jolla, CA) was used to analyze qPCR gene 
expression data. Biological group averages were compared using the Student’s t test. Significance for all 






Sequence of CYP72A68 cDNA is highly similar across M. truncatula accessions 
 Cytochrome P450 enzymes (CYPs) are members of a large superfamily of proteins encoded in a 
wide array of organisms.  In plants, CYPs play important roles in detoxification and biosynthesis of 
specialized metabolites (Bak et al., 2011). In M. truncatula, CYP72A68 encodes the enzyme responsible 
for oxidation of triterpene hemolytic sapogenins at the C-23 position (Fukushima et al., 2013) and the 
conversion of oleanolic acid, 2β-OH-oleanolic acid, and bayogenin into hederagenin, bayogenin, and 
medicagenic acid, respectively (Biazzi et al., 2015)(Figure 2). Gene expression of CYP72A68 is induced 
by herbivory in A17 and PRT178 plants, but not in ESP105 plants, and accumulation of medicagenic acid, 
a product of CYP72A68 oxidation, in foliar tissue is approximately 18 times lower in ESP105 than it is in 
A17 (Rogers, 2015). The cDNA of CYP72A68 synthesized from RNA extracted from the roots of A17, 
ESP105, and PRT178 M. truncatula plants was sequenced to identify single nucleotide polymorphisms 
(SNPs) among the accessions that could be used as molecular markers for confirming the presence of 
male parent DNA in putative cross plants. In addition, SNPs in the open reading frame could identify 
potentially important differences in amino acid residue sequences between accessions.   
 
PRT178          ----CGAGGAAAACATTTCACACTTAGTTTAGTTTTACTATTACAAACAAAGAAATGGAA  
ESP105          ---TCGAGGAAAACATTTCACACTTAGTTTAGTTTTACTATTACAAACAAAGAAATGGAA  
A17             ----CGAGGAAAACATTTCACACTTAGTTTGGTTTTACTATTACAAACAAAGAAATGGAA  
 
PRT178      TTATCTTGGGAAGCAAAATCAGCCATAATTCTAATCACTGTGACATTTGGTTTGGTATAC  
ESP105      TTATCTTGGGAAGCAAAATCAGCCATAATTCTAATCACTGTGACATTTGGTTTGGTATAC  
A17       TTATCTTGGGAAACAAAATCAGCCATAATTCTCATCACTGTGACATTTGGTTTGGTATAC  
    
PRT178        GCATGGAAGGTATTGAATTGGATGTGGCTGAAGCCAAAGAAGATAGAGAAGCTTTTAAGA 
ESP105      GCATGGAGGGTATTGAATTGGATGTGGCTGAAGCCAAAGAAGATAGAGAAGCTTTTAAGA 
A17      GCATGGAGGGTATTGAATTGGATGTGGCTGAAGCCAAAGAAGATAGAGAAGCTTTTAAGA 
        
PRT178      GAACAAGGCCTTCAAGGGAATCCTTATAGACTTTTGCTTGGAGATGCAAAGGATTATTTT 
ESP105          GAACAAGGCCTTCAAGGGAATCCTTATAGACTTTTGCTTGGAGATGCAAAGGATTATTTT 
A17      GAACAAGGCCTTCAAGGGAACCCTTATAGACTTTTGCTTGGAGATGCAAAGGATTATTTT 
 
PRT178     GTAATGCAAAAGAAAGTTCAATCCAAACCCATGAATCTATCTGATGATATTGCACCACGT 
ESP105      GTAATGCAAAAGAAAGTTCAATCCAAACCCATGAATCTATCTGATGATATTGCACCACGT 
A17       GTGATGCAAAAGAAAGTTCAATCCAAACCCATGAATCTATCTGATGATATTGCGCCACGT 
 
PRT178     GTTGCTCCTTACATTCATCACGCTGTTCAAACTCATGGGAAAAAGTCTTTTATTTGGTTT 
ESP105      GTTGCTCCTTACATTCATCACGCTGTTCAAACTCATGGGAAAAAGTCTTTTATTTGGTTT 




PRT178     GGAATGAAACCATGGGTGATTCTCAATGAACCTGAACAAATAAGAGAAGTATTCAACAAG 
ESP105     GGAATGAAACCATGGGTGATTCTCAATGAACCTGAACAAATAAGAGAAGTATTCAACAAG 
A17      GGAATGAAACCATGGGTGATTCTCAATGAACCTGAACAAATAAGAGAAGTATTCAACAAG 
 
PRT178      ATGTCTGAGTTCCCAAAGGTTCAATATAAGTTTATGAAGTTAATAACTCGCGGTCTTGTT 
ESP105     ATGTCTGAGTTCCCAAAGGTTCAATATAAGTTTATGAAGTTAATAACTCGCGGTCTTGTT 
A17      ATGTCTGAGTTCCCAAAGGTTCAATATAAGTTTATGAAGTTAATAACTCGCGGTCTTGTT 
      
PRT178     AAACTAGAAGGAGAAAAGTGGAGCAAGCATAGAAGAATAATCAACCCTGCGTTTCACATG 
ESP105     AAACTAGAAGGAGAAAAGTGGAGCAAGCATAGAAGAATAATCAACCCTGCGTTTCACATG 
A17      AAACTAGAAGGAGAAAAGTGGAGCAAGCATAGAAGAATAATCAACCCTGCGTTTCACATG 
 
PRT178     GAAAAGTTGAAGATTATGACACCAACATTCTTGAAAAGCTGCAATGATTTGATTAGCAAT 
ESP105     GAAAAATTGAAGATTATGACACCAACATTCTTGAAAAGCTGCAATGATTTGATTAGCAAT 
A17      GAAAAATTGAAGATTATGACACCAACATTCTTGAAAAGCTGCAATGATTTGATTAGCAAT 
 
PRT178     TGGGAAGAAAAGTTGTCTTCAAATGGATCATGTGAAATGGACATATGGCCTTCCCTTCAG 
ESP105     TGGGAAGAAAAGTTGTCTTCAAATGGATCATGTGAAATGGACATATGGCCTTCCCTTCAG 
A17      TGGGAAAAAATGTTGTCTTCAAATGGATCATGTGAAATGGACGTATGGCCTTCCCTTCAG 
 
PRT178     AGCTTGACAAGTGATGTTATCGCTCGTTCGTCATTTGGAAGTAGTTATGAAGAAGGAAGA 
ESP105     AGCTTGACAAGTGATGTTATCGCTCGTTCGTCATTTGGAAGTAGTTATGAAGAAGGAAGA 
A17      AGCTTGACAAGTGATGTTATCGCTCGTTCGTCATTTGGAAGTAGTTATGAAGAAGGAAGA 
 
PRT178     AAAGTATTTCAACTTCAAATAGAGCAAGGTGAACTTATAATGAAAAATCTAATGAAATCT 
ESP105     AAAGTATTTCAACTTCAAATAGAGCAAGGTGAACTTATAATGAAAAATCTAATGAAATCT 
A17       AAAGTATTTCAACTTCAAATAGAGCAAGGTGAACTTATAATGAAAAATCTAATGAAATCT 
 
PRT178     TTAATCCCTTTATGGAGGTTTTTACCTACCGCTGATCATAGAAAGATAAATGAAAATGAA 
ESP105     TTAATCCCTTTATGGAGGTTTTTACCTACCGCTGATCATAGAAAGATAAATGAAAATGAA 
A17      TTAATCCCTTTATGGAGGTTTTTACCTACCGCTGATCATAGAAAGATAAATGAAAATGAA 
 
PRT178          AAACAAATAGAAACTACTCTTAAGAATATAATTAACAAGAGGGAAAAAGCAATTAAGGCA 
ESP105     AAACAAATAGAAACTACTCTTAAGAATATAATTAACAAGAGGGAAAAAGCAATTAAGGCA 
A17      AAACAAATAGAAACTACTCTTAAGAATATAATTAACAAGAGGGAAAAAGCAATTAAGGCA 
 
PRT178     GGTGATGCCACTGAGAATGACTTATTAGGTCTCCTCCTAGAGTCGAACCACAGAGAAATT 
ESP105     GGTGATGCCACTGAGAATGACTTATTAGGTCTCCTCCTAGAGTCGAACCACAGAGAAATT 
A17      GGTGAAGCCACTGAGAATGACTTATTAGGTCTCCTCCTAGAGTCGAACCACAGAGAAATT 
 
PRT178     AAAGAACATGGAAACGTCAAGAATATGGGATTGAGTCTTGAAGAAGTAGTCGGGGAATGC 
ESP105     AAAGAACATGGAAACGTCAAGAATATGGGATTGAGTCTTGAAGAAGTAGTCGGGGAATGC 
A17      AAAGAACATGGAAACGTCAAGAATATGGGATTGAGTCTTGAAGAAGTAGTCGGGGAATGC 
 
PRT178     AGGTTATTCCATGTTGCAGGGCAAGAGTCTACTTCAGATTTGCTTGTTTGGACGATGGTG 
ESP105     AGGTTATTCCATGTTGCAGGGCAAGAGACTACTTCAGATTTGCTTGTTTGGACGATGGTG 
A17      AGGTTATTCCATGTTGCAGGGCAAGAGACTACTTCAGATTTGCTTGTTTGGACGATGGTG 
 
PRT178     TTGTTGAGTAGGTACCCTGATTGGCAAGAACGTGCAAGGAAGGAAGTATTAGAGATATTT 
ESP105     TTGTTGAGTAGGTACCCTGATTGGCAAGAACGTGCAAGGAAGGAAGTATTAGAGATATTT 
A17      TTGTTGAGTAGGTACCCTGATTGGCAAGAACGTGCAAGGAAGGAAGTATTAGAGATATTT 
 
PRT178     GGCAATGAAAAACCCGACTTTGATGGACTAAATAAACTTAAGATTATGGCCATGATTTTG 
ESP105     GGCAATGAAAAACCCGACTTTGATGGACTAAATAAACTTAAGATTATGGCCATGATTTTG 
A17      GGCAATGAAAAACCCGACTTTGATGGACTAAATAAACTTAAGATTATGGCCATGATTTTG 
 
PRT178     TATGAGGTTTTGAGGTTGTACCCTCCTGTAACCGGCGTTGCTCGAAAAGTTGAGAATGAT 
ESP105     TATGAGGTTTTGAGGTTGTACCCTCCTGTAACCGGCGTTGCTCGAAAAGTTGAGAATGAT 
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A17      TATGAGGTTTTGAGGTTGTACCCTCCTGTAACCGGCGTTGCTCGAAAAGTTGAGAATGAT 
         
PRT178     ATAAAACTTGGAGACTTGACATTATATGCTGGAATGGAGGTTTACATGCCAATTGTTTTG 
ESP105     ATAAAACTTGGAGACTTGACATTATATGCTGGAATGGAGGTTTACATGCCAATTGTTTTG 
A17      ATAAAACTTGGAGACTTGACATTATATGCTGGAATGGAGGTTTACATGCCAATTGTTTTG 
 
PRT178     ATTCACCATGATTGTGAACTATGGGGTGATGATGCTAAGATTTTCAATCCTGAGAGATTT 
ESP105     ATTCACCATGATTGTGAACTATGGGGTGATGATGCTAAGATTTTCAATCCTGAGAGATTT 
A17      ATTCACCATGATTGTGAACTATGGGGTGATGATGCTAAGATTTTCAATCCTGAGAGATTT 
 
PRT178     TCTGGTGGAATTTCCAAAGCAACAAACGGTAGATTTTCATATTTTCCGTTTGGAGCGGGT 
ESP105     TCTGGTGGAATTTCCAAAGCAACAAACGGTAGATTTTCATATTTTCCGTTTGGAGCGGGT 
A17      TCTGGTGGAATTTCCAAAGCAACAAACGGTAGATTTTCATATTTTCCGTTTGGAGCGGGT 
 
PRT178     CCTAGAATCTGCATTGGACAAAACTTTTCCCTGTTGGAAGCAAAGATGGCAATGGCATTG 
ESP105          CCTAGAATCTGCATTGGACAAAACTTTTCCCTGTTGGAAGCAAAGATGGCAATGGCATTG 
A17      CCTAGAATCTGCATTGGACAAAACTTTTCCCTGTTGGAAGCAAAGATGGCAATGGCATTG 
 
PRT178     ATTTTAAAGAATTTTTCATTTGAACTTTCTCAAACATATGCTCATGCTCCATCTGTGGTG 
ESP105     ATTTTACAGAATTTTTCATTTGAACTTTCTCAAACATATGCTCATGCTCCATCTGTGGTG 
A17      ATTTTAAAGAATTTTTCATTTGAACTTTCTCAAACATATGCTCATGCTCCATCTGTGGTG 
 
PRT178     CTTTCTGTTCAGCCACAACATGGTGCTCATGTTATTCTACGCAAAATCAAAACATAAAAA 
ESP105     CTTTCTGTTCAGCCACAACATGGTGCTCATGTTATTCTACGCAAAATCAAAACATAAAAA 
A17      CTTTCTGTTCAGCCACAACATGGTGCTCATGTTATTCTACGCAAAATCAAAACATAAAAA 
     
PRT178     CAACATCAGAGAAGAAACGTATGTCA---------------------------------- 
ESP105     CAACATCAGAGAAGAAACGTATGT------------------------------------ 
A17      CAACATCAGAGAAGAAACGTATGTC----------------------------------- 
Figure 3. Alignment of CYP72A68 cDNA sequences in A17, ESP105, and PRT178 M. truncatula plants. 
Sequences were 99% similar with 16 SNPs, shaded light gray. Start and stop codons are shaded dark 
gray.  
 
Alignment of accession CYP72A68 cDNA sequences revealed high sequence similarity (Figure 
3). There were 13 SNPs and 99.2% similarity between the A17 and ESP105 sequences, 15 SNPs and 
99.1% similarity between the A17 and PRT178 sequences, and four SNPs and 99.8% similarity between 
the ESP105 and PRT178 sequences. There are two apparent isoforms for CYP72A68 in the M. 
truncatula genome, annotated as Medtr2g055430 and Medtr2g055470. The A17 CYP72A68 sequence 
showed 100% identity with Medtr2g05570 and 96.7% identity with Medtr2g055430. The predicted 
translation of the sequences was generated and the 520 amino acid sequences were aligned. There were 
six amino acid substitutions and 98.8% similarity between A17 and ESP105 sequences, seven 
substitutions and 98.7% similarity between A17 and PRT178 sequences, and three substitutions and 
99.4% similarity between ESP105 and PRT178 sequences. For seven out of the eight total substitutions 
among the accessions, where the ESP105 sequence disagreed with either the A17 or PRT178 sequence, 
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it agreed with the sequence of the remaining accession, either PRT178 or A17. However, at residue 485 
the ESP105 sequence differs from both of the high saponin producing accessions, containing a 
glutamine, while the A17 and PRT178 sequences have a lysine at this position.  
	  
	  
Figure 4. Phylogenetic relationships among CYP72A proteins in various plant species. A phylogenetic 
tree was generated based on the alignment of amino acid sequences of CYP72A proteins from 
Glycyrrhiza uralensis (Gu), Cajanus cajan (Cc), Cicer arietinum (Ca), the three Medicago truncatula (Mt) 
accessions, Arachis duranensis (Ad), Arabidopsis thaliana (At), Zea mays (Zm), Orzya sativa Japonica 




A BLASTp search of the NCBI non-redundant protein database using the A17 CYP72A68 amino 
acid sequence yielded similar sequences for CYP72A proteins from other plant species: CYP72A15 from 
Arabidopsis thaliana, a CYP72A15-like protein from Arachis duranensis, a CYP72A15-like protein from 
Oryza sativa Japonica, CYP72A154 from Glycyrrhiza uralensis, CYP72A1 from Catharanthus roseus, a 
CYP72A1-like protein from Morus notabilus, a CYP72A1-like protein from Cajanus cajan, CYP72A16 
from Zea mays, CYP72A219 from Panax ginseng, a CYP72A219-like protein from Vitus vinifera, a 
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CYP72A219-like protein from Glycine max, and a CYP72A219-like protein from Cicer arietinum.  The 
protein CYP72A1 from C. roseus (Madagascar periwinkle) has been functionally characterized as the 
ring-opening enzyme that converts loganin into secologanin, an early step in indole alkaloid synthesis 
(Irmler et al., 2000). The enzyme CYP72A154 from G. uralensis (Chinese licorice) has been functionally 
characterized as a C-30 oxidase in the aglycone modification phase of biosynthesis of the triterpenoid 
saponin glycyrrhizin. The M. truncatula enzyme CYP72A63 was shown to possess the same activity, but 
no C-30 oxidated aglycones have yet been detected in profiled saponin extracts (Seki et al., 2011). The 
phylogenetic tree in Figure 4 shows that proteins from legumes were more closely related to CYP72A68 
in M. truncatula than proteins from non-legume plants.   
The amino acid sequences for M. truncatula A17, ESP105, and PRT178 CYP72A68 and for the 
proteins in Figure 4 from the five legume species were aligned to investigate whether the amino acid 
substitution at residue 485 of the ESP105 sequence resulted in a chemically distinct amino acid in a 
position that was otherwise highly conserved across all the legume species (Figure 5). The protein 
sequences for all five legume species agree with the M. truncatula ESP105 CYP72A68 protein sequence 















Figure 5. Alignment of amino acid sequences for CYP72A proteins in various legumes. Amino acid 
sequences for CYP72A68 in M. truncatula accessions A17, PRT178, and ESP105 were aligned with 
amino acid sequences for a CYP72A219-like protein in G. max, a CYP72A15-like protein in A. 
duranensis, CYP72A153 in G. uralensis, a CYP72A1-like protein in C. cajan, and a CYP72A219-like 
protein in C. areitinum. Amino acids that are identical across the sequences are shaded black, while 
amino acids that are chemically similar across the sequences are shaded dark gray. No shading indicates 




Confirmation of the presence of male parent DNA in putative cross progeny 
 Crosses were made between accessions with high levels of triterpene saponin accumulation, A17 
or PRT178, and an accession with low levels of triterpene saponin accumulation, ESP105. The resulting 
population could potentially be used to investigate and identify the genetic components controlling 
saponin synthesis in M. truncatula. Two separate crosses of A17 and ESP105 M. truncatula plants in 
which A17 acted as the female parent and ESP105 acted as the male parent were performed, as well two 
separate reciprocal crosses of ESP105 and PRT178 plants in which each accession acted as the female 
parent in one cross and the male parent in the other cross. Successful fertilization resulted in the 
formation of a seedpod containing three to ten seeds of the F1 generation. Due to the possibility of 
unwanted self-fertilization, the presence of the desired male parent DNA was confirmed in all putative F1 
plants. Primers were designed around SNPs in the A17, ESP105, and PRT178 CYP72A68 cDNA 
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sequences specific to the male parent accession and used to amplify DNA from parent accessions and 
putative F1 plants. Six A17 x ESP105, two ESP105 (female) x PRT178 (male) and one PRT178 (female) 
x ESP105 (male) F1 plants were tested and all were confirmed to be crosses by the amplification of male 
parent accession markers (Figure 6). Seed resulting from self-fertilization of confirmed F1 plants and their 
clonal cuttings was collected.  
 
	  
Figure 6. Confirmation of presence of male parent DNA in putative cross progeny. Primers based on 
SNPs in the A17 (A), ESP105 (E), and PRT178 (P) CYP72A68 cDNA sequences were used. DNA was 
amplified from the male parent accessions and from putative F1 plants (1-6 and X), but not in the female 
parent accessions or the no-template control (NTC) reactions. A17 x ESP105 (panel A), ESP105 x 




Cross progeny and parent accession leaf extracts display varying levels of hemolytic activity 
 Because saponin accumulation in leaves varies widely in the parents, F2 progeny from the 
crosses described above were predicted to have varying levels of hemolytic saponins segregating in the 
population. To screen the A17 x ESP105 F2 generation for inheritance of triterpene saponin accumulation 
quickly and cheaply, the hemolytic activity of leaf extracts from F2 and parent accession plants was 
assessed by application of extracts to blood agar Petri plates and observation of hemolytic clearing zones 
(Figure 7). Leaf extracts from the A17 parent accession produced high levels of hemolysis, while extracts 
from the ESP105 parent accession did not produce any visible hemolysis. Hemolytic activity of extracts 
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from 141 F2 plants resulting from self-fertilization of all six confirmed F1 plants (Figure 6A) was tested. 
Hemolysis caused by A17 and F2 leaf extracts was expressed as d/ESP by measuring the clearing zone 
diameter (d) and dividing it by the average diameter of the three ESP105 wells on the same Petri plate. 
Three distinct hemolysis phenotypes were observed; extracts from 28 F2 plants caused no visible 
hemolysis, resembling the ESP105 parent accession, extracts from another 28 F2 plants caused high 
levels of hemolysis resembling those caused by the A17 parent accession, and 85 F2 plants caused 
intermediate levels of hemolysis between the high and low levels caused by the parent accessions. The 
ratio of high:medium:low hemolysis phenotype plants was therefore approximately 1:3:1. The presence of 
the intermediate phenotype and 1:3:1 F2 phenotypic ratio suggests that inheritance of hemolytic saponin 
accumulation could depend on incomplete dominance involving more than a single gene with recessive 




Figure 7. Segregation of hemolytic saponin levels in A17 x ESP105 F2 plants as demonstrated on blood-
agar Petri plates. F2 progeny demonstrate high, medium or low levels of hemolytic activity. The 
high:medium:low segregation ratio was approximately 1:3:1, suggesting that several genes contribute to 
regulation of saponin accumulation. 
   
 
 
Expression of saponin synthesis genes correlates with A17 x ESP105 F2 hemolysis phenotypes 
 Quantitative reverse transcriptase PCR (qRT-PCR) was used to examine the relationship 
between the three hemolysis phenotypes observed in the A17 x ESP105 F2 generation and expression of 
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saponin synthesis genes. RNA was extracted from three F2 plants each with high, medium, and low 
hemolysis phenotypes, as well as three plants each of the A17 and ESP105 parent accessions. Leaves 
were mechanically wounded 3.5 hours prior to extraction to induce expression of saponin synthesis 
genes. Gene expression was evaluated using the 2-ΔΔCt method which utilizes a reference control sample 
and reference gene target to evaluate expression of the gene of interest. The parent accession ESP105 
was chosen as the reference control sample, and the sequence encoding actin, an established 
housekeeping gene whose expression is similar in the varying genotypes of this experiment, was used as 
the reference gene.  
 
	  
Figure 8. Relative gene expression of CYP716A12 in M. truncatula leaves subjected to mechanical 
damage, taken from A17, ESP105, and from A17xESP105 F2 plants with high, medium, and low 
hemolysis phenotypes. Expression ratios were plotted relative to ESP105. Error bars indicate SEM (n=3). 
Statistical significance calculated by Student’s t test (P < 0.1). For correlation between CYP716A12 gene 




 CYP716A12 gene expression in A17 and ESP105 parent accessions and F2 progeny correlated 
with the observed hemolysis phenotypes (Figure 8). CYP716A12 encodes the enzyme responsible for the 
conversion of β-amyrin into oleanolic acid through oxidation at the C-28 position, the first committed step 
in hemolytic saponin synthesis in M. truncatula. The A17 parent accession, which accumulates high 
levels of hemolytic saponins and caused high levels of hemolysis in the blood agar assay, had much 
higher levels of CYP716A12 expression than the ESP105 parent accession that accumulates low levels 
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of hemolytic saponins and did not cause any visible hemolysis. CYP716A12 expression in A17 x ESP105 
F2 plants that caused high levels of hemolysis was even higher than that of A17, though the difference 
was not statistically significant. Expression of CYP716A12 in F2 plants with low levels of hemolysis was 
similar to ESP105 expression levels, while expression in medium hemolysis phenotype F2 plants was 
higher than, but not significantly different from, ESP105 expression.  The correlation between 
CYP716A12 gene expression and d/ESP values was positive and had an R2 value of 0.748.  
 
	  
Figure 9. Relative gene expression of CYP72A67 in M. truncatula leaves subjected to mechanical 
damage, taken from A17, ESP105, and from A17xESP105 F2 plants with high, medium, and low 
hemolysis phenotypes. Expression ratios were plotted relative to ESP105. Error bars indicate SEM (n=3). 
Statistical significance calculated by Student’s t test (P < 0.05). For correlation between CYP72A67 gene 




 Oleanolic acid formed by the CYP716A12 enzyme can be further modified by oxidation at the C-2 
position catalyzed by the CYP72A67 enzyme to form additional sapogenins. The pattern of CYP72A67 
gene expression in A17 x ESP105 F2 plants was comparable to that of CYP716A12 expression and 
hemolytic activity (Figure 9). Accumulation of CYP72A67 transcripts was approximately six times higher 
in A17 parent accession plants than in ESP105 plants, in agreement with the higher levels of saponin 
accumulation and hemolytic activity observed in A17 plants. In F2 plants from the A17 x ESP105 cross 
with high levels of hemolysis in blood agar assays, CYP72A67 mRNA expression levels were similar to 
A17 expression levels in that they were significantly higher than ESP105 expressions levels (P=0.0008). 
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Interestingly, they were also significantly higher than A17 expression levels (P=0.033). Expression of 
CYP72A67 transcripts in low-hemolysis phenotype F2 plants was similar to expression in ESP105 plants, 
and also significantly lower than expression in A17 parents and the high-hemolysis F2 plants (P<0.01). 
Expression of CYP72A67 mRNA in medium-hemolysis F2 plants was higher than expression in low-
hemolysis plants and lower than expression in high-hemolysis plants, but not significantly different from 
either due to high variability in gene expression values. The correlation between CYP72A67 gene 
expression and d/ESP values was positive and had an R2 value of 0.719.  
 
	  
Figure 10. Relative gene expression of CYP72A68 in M. truncatula leaves subjected to mechanical 
damage, taken from A17, ESP105, and from A17 x ESP105 F2 plants with high, medium, and low 
hemolysis phenotypes. Expression ratios were plotted relative to ESP105. Error bars indicate SEM (n=3). 
Statistical significance calculated by Student’s t test (P < 0.05). For correlation between CYP72A68 gene 




 Oleanolic acid can also be modified by oxidation at the C-23 position, in a reaction catalyzed by 
the CYP72A68 enzyme. Accumulation of CYP72A68-encoding transcripts in A17 x ESP105 F2 plants was 
strongly correlated with the three observed hemolysis phenotypes (Figure 10). Similar to the expression 
pattern seen for CYP716A12 and CYP72A67, CYP72A68 expression in the A17 parent accession was 
approximately 32-times higher and significantly different from expression in ESP105 (p<0.0001). High-
hemolysis F2 plants demonstrated very similar expression levels of CYP72A68 that were also significantly 
higher than expression levels in ESP105 (P=0.0001). CYP72A68 expression in low-hemolysis F2 plants 
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was similar to that in ESP105 and significantly lower than expression in A17 and high-hemolysis F2 plants 
(P<0.001), while CYP72A68 expression in medium hemolysis F2 plants was significantly higher than that 
of ESP105 and low-hemolysis F2 plants (P<0.01) and significantly lower than that of A17 and high-
hemolysis F2 plants (P<0.001). The correlation between CYP72A68 gene expression and d/ESP values 





Saponins are a family of specialized metabolites produced by a variety of plants as a means of defense. 
They are used in many industrial applications, including as additives in food and cosmetic products, due 
their emulsifying, foaming, detergent, and surfactant properties. There has been interest in utilizing 
saponins in agriculture to protect crops from a wide range of pests and as feed additives to improve 
livestock performance. Saponins also possess many properties that could be exploited to improve human 
health, including hypocholesterolemic, immunostimulatory, hypoglycemic, neuroprotective, antibacterial, 
antiviral, and cytotoxic activities. In spite of their usefulness, the genetic basis for the saponin biosynthetic 
pathway has not been completely elucidated. The annual legume M. truncatula accumulates triterpene 
saponins constitutively and in response to herbivory in its roots, stems, leaves, seedpods, and seeds. 
While the enzymes involved in many of the steps of saponin biosynthesis in M. truncatula have been 
identified and functionally characterized, little is known about the genes responsible for regulation of 
those enzymes. The M. truncatula species encompasses genetically distinct accessions that vary in the 
levels and types of saponins that they produce. We hypothesized that populations generated by crosses 
between an accession that accumulates low levels of saponins in foliar tissue, ESP105, and an accession 
that accumulates high levels of saponin in foliar tissue, A17 or PRT178, could be used to investigate the 
genetic components controlling saponin synthesis. Three types of crosses were performed, A17 x 
ESP105, PRT178 x ESP105, and ESP105 x PRT178, and confirmed using accession molecular markers 
based on SNPs found in the cDNA sequence of CYP72A68, an enzyme involved in later steps of 
hemolytic triterpene saponin biosynthesis. Hemolytic saponin accumulation inheritance in A17 x ESP105 
F2 progeny was evaluated by measuring hemolytic activity of leaf extracts, and three distinct hemolysis 
phenotypes occurring at a ratio of 1:3:1 were observed. By investigating gene expression in F2 progeny 
exhibiting the three hemolysis phenotypes, we found that hemolytic saponin accumulation correlated with 
expression of three genes involved in hemolytic saponin biosynthesis, CYP716A12, CYP72A67, and 
CYP72A68.  
 A CYP72A68 cDNA from M. truncatula A17, ESP105, and PRT178 plants was sequenced to 
identify SNPs among the accessions that could be used as molecular markers to confirm the presence of 
male parent DNA in putative crosses. The cDNA and protein sequences obtained were very similar with 
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only 16 SNPs and 8 amino acid substitutions across the accessions. The ESP105 and PRT178 
sequences were more similar to each than they were to the A17 sequence, with 99.8% similarity at the 
nucleotide level and 99.4% similarity at the amino acid level. The CYP72A68 enzyme is a C-23 oxidase 
required for the production of the triterpene backbones hederagenin, bayogenin, and medicagenic acid, 
listed in order of increasing oxidation at the C-23 position (Biazzi et al., 2015; Fukushima et al., 2013). 
Two isoforms of the CYP72A68 gene have been identified in the M. truncatula genome, Medtr2g055430 
and Medtr2g055470, which show 97% identity at the nucleotide level and 96% identity at the amino acid 
level. The Medtr2g055470 version demonstrated a higher efficiency than the Medtr2g055430 version 
when each was expressed in a yeast system and supplied with substrates. Both isoforms more effectively 
transformed substrates carrying a C-2 hydroxl group than those lacking C-2 oxidation, suggesting that 
CYP72A68-mediated oxidation at the C-23 position of triterpene aglycones preferentially occurs after 
CYP72A67-mediated oxidation at the C-2 position (Biazzi et al., 2015). The obtained A17 CYP72A68 
cDNA sequence shows 100% identity with the Medtr2g055470 cDNA. Expression of CYP72A68 in foliar 
tissue is induced by herbivory in A17 and PRT178 plants but not in ESP105 (Rogers, 2015), and A17 
plants constitutively accumulate higher levels of hemolytic triterpene saponins, the products of CYP72A68 
activity, than ESP105 in foliar tissue (Figure 7). This suggests that CYP72A68 gene expression is 
differentially regulated between the high saponin producing accessions A17 and PRT178 and the low 
saponin producing accession ESP105 and/or that the protein encoded by the ESP105 version of the 
CYP72A68 gene is non-functioning. Although the amino acid sequences of the three accessions are very 
similar, even a single substitution can have an effect on protein function and processing. For seven of the 
eight amino acid substitutions found among the accessions, where the ESP105 sequence differs from the 
A17 sequence, it is the same as the PRT178 sequence, and vice versa. This would suggest that these 
substitutions, present in both high and low saponin producing accessions, do not lead to a non-
functioning CYP72A68 protein. However, there is one substitution at residue 485 for which ESP105 has 
an amino acid, glutamine, different from the lysine present in the A17 and PRT178 sequences. The 




 The cytochrome P450 superfamily of proteins is made up of hemothiolate enzymes with highly 
divergent sequences that catalyze a wide range of reactions and are present in all organisms from 
humans to bacteria. Plant cytochrome P450s control the synthesis of phytohormones and signaling 
molecules, such as gibberellins and jasmonates, metabolize and detoxify xenobiotics like pesticides and 
pollutants, and are involved in the biosynthesis of pigments, antioxidants, volatiles, allelochemicals, and 
defense compounds. The superfamily is divided into families and subfamilies with members of the same 
family generally sharing at least 40% identity and members of the same subfamily sharing at least 55% 
identity (Bak et al., 2011). The M. truncatula CYP72A68 protein that was sequenced is part of the A 
subfamily of the 72 family of cytrochrome P450 superfamily. Twelve CYP72A and CYP72A-like proteins 
from twelve different plant species were chosen based on similarity to the M. truncatula A17 CYP72A68 
sequence and relevance of the species and protein function and aligned with the three M. truncatula 
CYP72A68 sequences to generate a phylogenetic tree (Figure 4). Five of the proteins were from 
legumes, including Arachis duranensis, an herb used in peanut research, Glycyrrhiza uralensis (Chinese 
licorice), the important crop Glycine max (soybean), Cajanus cajan (pigeon pea), and Cicer arietinum 
(chickpea), and seven of the proteins were from non-legumes, including the model organism Arabidopsis 
thaliana, Catharanthus roseus (Madagascar periwinkle), the medicinal plant Panax ginseng, Zea mays 
(corn), Oryza sativa (rice), Vitus vinifera (common grape vine), and Morus notabilus (mulberry tree). The 
C. roseus protein CYP72A1 has been functionally characterized as the ring-opening enzyme responsible 
for the conversion of loganin into secologanin in the early steps of indole alkaloid biosynthesis (Irmler et 
al., 2000), and the G. uralensis CYP72A154 protein has been functionally characterized as a C-30 
oxidase responsible for aglycone modification in the biosynthesis of the oleanane-type triterpene saponin 
glycyrrhizin (Seki et al., 2011). The remaining proteins have been annotated as CYP72A proteins or as 
similar to CYP72A, and their function is unknown. The uncharacterized CYP72A proteins from legumes 
clustered around the M. truncatula CYP72A68 and G. uralensis CYP72A154 proteins, while the 
uncharacterized CYP72A proteins from non-legumes clustered around the C. roseus CYP72A1 protein. 
This could indicate that the two groups of proteins may function differently; with the uncharacterized 
CYP72A proteins from legumes catalyzing reactions similar to those catalyzed by CYP72A68 and 
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CYP72A154, and uncharacterized CYP72A proteins from non-legumes catalyzing reactions similar to the 
reaction catalyzed by CYP72A1.  
 The three M. truncatula CYP72A68 sequences were aligned with the CYP72A protein sequences 
from the five legume species to investigate amino acid conservation at residue 485. The sequences for 
the five proteins, including that of the characterized G. uralensis CYP72A154 enzyme, agreed with the 
ESP105 CYP72A68 sequence and contained a glutamine at this position. At every position that the 
CYP72A68 sequence from the low saponin producing accession ESP105 differed from one or both of the 
sequences from the high saponin producing accessions A17 and PRT178, it agreed with the sequences 
of either the other high-saponin producing accession or CYP72A sequences from other legumes. This 
suggests that the low levels of hemolytic saponin accumulation present in ESP105 plants are not due to 
allelic variation in synthesis genes resulting in non-functioning enzymes, but are instead due to differential 
regulation of those synthesis genes and/or enzymes resulting in lower levels of enzyme activity. 
 Two crosses between A17 and ESP105 plants in which A17 acted as the female parent and two 
crosses between ESP105 and PRT178 plants in which each accession had a turn acting as the female 
parent were made and successfully confirmed using primers based on the SNPs found in the CYP72A68 
cDNA sequence. Seed resulting from self-fertilization of the F1 generation and its clonal cuttings was 
collected for all cross types. The A17 x ESP105 population has already begun to be utilized in this thesis 
research for the study of saponin accumulation inheritance. All the populations should prove useful for the 
further study of the genetic basis of saponin biosynthesis and the study of the relationship between 
saponin production and various aspects of M. truncatula biology. A cross between a genotype of the 
crucifer Barbarea vulgaris that was resistant to the flea beetle larvae Phyllotreta nemorum and a 
susceptible genotype was used to identify bioactive compounds involved in defense by assaying flea 
beetle larvae susceptibility and metabolite levels of the F2 offspring and identifying metabolites that 
negatively correlated with larvae survival (Kuzina et al., 2009). Populations of M. truncatula resulting from 
crosses between accessions demonstrating varying levels of resistance to the spotted alfalfa aphid 
Therioaphis trifolii allowed for the characterization of T. trifolii resistance as phloem-mediated and 
involving tolerance and antibiosis and the identification of three quantitative trait loci involved in distinct 
modes of aphid defense (Kamphuis et al., 2013).   
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 The hemolytic activity of leaf extracts from A17 x ESP105 F2 plants was quantified using sheep’s 
blood agar Petri plates to screen for inheritance of hemolytic saponin accumulation traits. Three distinct 
hemolysis phenotypes were observed, a high hemolysis phenotype that resembled the level of hemolysis 
caused by the A17 parent accession, a low hemolysis phenotype that caused no visible hemolysis similar 
to the ESP105 parent accession, and a medium hemolysis phenotype that caused an intermediate level 
of hemolysis between that caused by the A17 and ESP105 parent accessions. The phenotypic ratio of 
high:medium:low hemolysis was approximately 1:3:1. The presence of the medium hemolysis phenotype 
and the 1:3:1 phenotypic ratio suggests that inheritance of hemolytic saponin accumulation could depend 
on incomplete dominance involving more than a single gene with recessive and dominant alleles. 
Investigation of gene expression in A17 and ESP105 parent accessions and F2 plants exhibiting high, 
medium, or low hemolysis phenotypes showed that expression of three genes involved in late steps of 
hemolytic saponin biosynthesis, CYP716A12, CYP72A67, and CYP72A68, correlated with the observed 
hemolysis phenotypes. This indicates that accumulation of hemolytic saponins is correlated with 
expression of genes encoding saponin synthesis enzymes and suggests that the differential regulation of 
saponin synthesis enzymes that results in high levels of hemolytic saponins in A17 foliar tissue and low 
levels of saponins in ESP105 foliar tissue occurs at the transcription level.  
 The association between saponin accumulation and saponin synthesis gene expression has been 
previously explored by several papers that address methyl jasmonate elicitation in M. truncatula. Suzuki 
et al. (2002) identified and functionally characterized squalene synthase, squalene epoxidase, and β-
amyrin synthase enzymes and then developed a methyl jasmonate-induced root cell suspension culture 
to show that transcript levels of the newly identified enzymes and saponin accumulation levels were both 
increased after methyl jasmonate treatment. This methyl jasmonate-inducible cell culture system was 
further optimized by Suzuki et al. (2004) and confirmed by Broeckling et al. (2005) to produce increased 
levels of triterpene saponins. Achnine et al. (2005) and Naoumkina et al. (2010) were able to identify and 
functionally characterize three UDP-dependent glycosyltransferase enzymes by using this system to 
focus on candidate genes with methyl jasmonate-induced expression. Naoumkina et al. (2010) also found 
that expression of cytochrome P450 gene family members was increased after methyl jasmonate 
elicitation. Carelli et al. (2011) addressed the association between saponin accumulation and saponin 
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synthesis gene expression by showing a relationship between expression of CYP716A12 and hemolytic 
saponin accumulation in leaves, roots, stems, flowers, and pods of M. truncatula plants at different 
developmental stages.  
 Research on regulation of saponin biosynthesis in M. truncatula has been limited. Pollier et al. 
(2013) discovered an RING membrane anchor-like E3 ubiquitin ligase, makibishi 1 (Mkb1) involved in 
endoplasmic reticulum-associated degradation that was transcriptionally upregulated in response to 
methyl jasmonate elicitation concurrently with saponin genes encoding HMGR, squalene synthase, 
squalene epoxidase, β-amyrin synthase, and CYP93E2. Transgenic M. truncatula hairy roots with 
knocked down Mkb1 accumulated higher amounts of monoglycosylated saponins and lower amounts of 
higher glycosylated saponins than control roots and had severe morphological deficiencies caused in part 
by the overaccumulation of bioactive monoglycosylated saponins. The Mkb1 ubiquitin ligase was shown 
to control the activity of the endoplasmic-reticulum-localized HMGR enzyme that serves as the rate-
limiting enzyme in the MVA pathway from which saponin synthesis originates. In control roots, methyl 
jasmonate application resulted in increased HMGR transcript levels, but HMGR protein levels remained 
stable, while in Mkb1 knockdown roots HMGR transcript and proteins levels both increased. Pollier et al. 
(2013) propose that Mkb1 may also manage other endoplasmic-reticulum-associated enzymes involved 
in saponin synthesis, including cytochrome P450s. While it is possible that Mkb1 or a similar protein could 
play a role in cytochrome P450 post-transcriptional regulation, this does not explain the vast differences 
in foliar hemolytic saponin accumulation that occur between A17 and ESP105 plants. The differences in 
hemolytic saponin accumulation between A17 and ESP105 plants are mirrored by differences in 
accumulation of transcripts encoding cytochrome P450s involved in hemolytic saponin synthesis, 
indicating that the regulation responsible for the different levels of hemolytic saponins in the foliar tissue 
A17 and ESP105 plants occurs at the transcription level.  
 Carelli et al. (2015) used a population derived from the crossing of two Medicago species, M. 
sativa and M. arborea, that accumulate differing levels of hemolytic and non-hemolytic triterpene 
saponins to analyze the variation in saponin accumulation across different progeny and plant organs, 
specifically leaves and roots, and the mechanisms underlying this variation. Saponin and sapogenin 
amounts and gene expression of β-amyrin synthase, CYP716A12, CYP72A67, CYP72A68, and 
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CYP93E2 were evaluated in the leaves and roots of cross progeny. They proposed that sapogenin 
biosynthesis in the leaves and roots may be controlled by different mechanisms. Hemolytic saponin 
content was higher and two-times less variable in the roots than in the leaves, suggesting a more 
stringent control mechanism in the roots. In addition, accumulation of the major hemolytic sapogenins, 
medicagenic acid, hederagenin, and bayogenin, correlated with accumulation of the non-hemolytic 
soyasapogenol B, and expression of hemolytic saponin synthesis genes, CYP716A12, CYP72A67, and 
CYP72A68 correlated with expression of the non-hemolytic saponin synthesis gene CYP93E2 in the roots 
but not in leaves, suggesting that the hemolytic and non-hemolytic branches of saponin synthesis are 
more coordinated in the roots than they are in the leaves. This is likely also true in M. truncatula, where 
roots accumulate higher levels of saponins than the aerial organs (Huhman et al., 2005). Moreover, while 
the ESP105 accession accumulates relatively low levels of saponins in foliar tissue compared to the A17, 
PRT178, and GRC43 accessions, it accumulates relatively very high levels of saponins in the roots 
compared to the other accessions (Table 4). Due to this accession variation in saponin accumulation in 
the roots, the cross populations generated in this thesis research, especially between ESP105 with very 
high root saponins and PRT178 with intermediate root saponins, could also be used to investigate the 
mechanisms controlling saponin synthesis in the roots. Carelli et al. (2015) also found that expression 
levels of the three hemolytic saponin synthesis genes were positively and significantly correlated in both a 
synchronic analysis of gene expression in 60 cross progeny plants and a diachronic analysis of gene 
expression in two cross families with variable sapogenin content at three different time points, indicating 
consistent genetic control of these genes. A comparison of the contents of various aglycones in the foliar 
tissue of F1 mother plants and F2 progeny found a significant correlation between mother and progeny 
plant aglycone levels for medicagenic acid only. The F1 versus F2 relationship was not significant for 
zanhic acid accumulation, but it was significant when the medicagenic acid:zanhic acid ratio was 
considered. This indicates that genetic control of the sapogenin pathway in foliar tissue is primarily 
focused on medicagenic acid, and that conversion of medicagenic acid into zanhic acid may be one 
method of controlling medicagenic acid levels. We also found that expression patterns of CYP716A12, 
CYP72A67, and CYP72A68 were similar to each other, all correlating with hemolytic activity of leaf 
extracts. In addition, A17 foliar accumulation of the non-hemolytic sapogenins, hederagenin, and 
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bayogenin is approximately three-, nine-, and six-times higher than ESP105 foliar accumulation, 
respectively, while A17 foliar accumulation of medicagenic and zanhic acid is 22- and 31-times higher 
than ESP105 foliar accumulation, respectively (Lloyd Sumner, unpublished data). This suggests that the 
genetic control of the sapogenin pathway responsible for the saponin accumulation differences between 
the A17 and ESP105 accessions may also be focused on medicagenic acid. As has already been noted, 
this regulation likely occurs at the transcriptional level. If accumulation of medicagenic acid were the 
primary focus of saponin synthesis regulation, CYP72A68, the enzyme responsible for medicagenic acid 
synthesis would be the primary target of possible transcription factors.  
 Mertens et al. (2016) identified two basic helix-loop-helix family transcription factors, triterpene 
saponin biosynthesis activating regulator 1 (TSAR1) and TSAR2 that act as specific regulators of 
triterpene saponin biosynthesis in M. truncatula. Overexpression of TSAR1 and TSAR2 in transgenic M. 
truncatula hairy roots resulted in increased expression of genes in the mevalonate pathway, β-amyrin 
synthase, aglycone-modifying cytochrome P450s, and glycosyltransferases but did not result in increased 
expression of sterol synthesis genes, demonstrating that TSAR1 and TSAR2 regulation encompasses 
and is specific to triterpene saponin synthesis. TSAR1 overexpression primarily increased expression of 
non-hemolytic saponin synthesis genes and production of soyasaponins, while TSAR2 overexpression 
specifically increased expression of hemolytic saponin synthesis genes and production of hemolytic 
saponins. Because this research was exclusively performed in hairy roots and mechanisms of saponin 
biosynthesis regulation may differ between root and leaf tissue (Carelli et al. 2015), it is possible that 
TSAR1 and TSAR2 may not function in M. truncatula foliar tissue in the same way that they were shown 
to function in hairy roots. Moreover, the 1:3:1 hemolysis phenotype ratio observed among A17 x ESP105 
F2 progeny does not match the standard 3:1 or 1:2:1 phenotypic ratios that indicate that a trait is 
controlled by one gene with a dominant and recessive allele or with codominant alleles, indicating that 
hemolytic saponin synthesis in M. truncatula foliar tissue is regulated by more than one gene. If TSAR2 
does regulate hemolytic saponin synthesis in foliar as well as root tissue, it is likely that there are other 
contributing transcription factors that have not yet been identified.   
 Using genetically distinct M. truncatula accessions that accumulate varying levels of foliar 
saponins as a reflection of the different locations and circumstances from which they originate, we were 
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able to investigate the genetic basis for control of saponin accumulation in leaves. The high conservation 
of the amino acid sequence for CYP72A68, a cytochrome P450 enzyme involved in modification of 
hemolytic sapogenins, across the accessions and the correlation between hemolytic saponin levels and 
expression of hemolytic saponin synthesis genes in the foliar tissue of A17 x ESP105 F2 progeny suggest 
that variation in hemolytic saponin accumulation among the accessions is not a result of allelic variation in 
genes encoding saponin synthesis enzymes, but a result of differential regulation of the expression of the 
genes encoding saponin synthesis enzymes. Three distinct phenotypes of hemolytic activity were 
observed among A17 x ESP105 F2 progeny at a ratio of 1:3:1 indicating that the proposed regulation 
responsible for the accession differences in foliar saponin accumulation is not controlled by a single gene 
with dominant and recessive alleles. While our understanding of the regulation of triterpene saponin 
synthesis in M. truncatula has been growing, especially with the recent discovery of transcription factors 
controlling saponin synthesis gene expression, our research indicates that there additional regulators that 
have not yet been identified. In the future, the CYP72A68 amino acid sequences from each accession 
could be expressed in yeast and supplied with substrate to confirm that the proteins function with similar 
efficiency. Saponin extracts from A17 x ESP105 progeny foliar tissue could be analyzed by HPLC to 
provide more specific information on differences in accumulation of various sapogenins and individual 
saponins, and expression of additional saponin synthesis genes, including those involved in soyasaponin 
synthesis and in earlier and later portions of the pathway, in the same foliar tissue could be analyzed by 
quantitative PCR to provide additional information on the regulation of saponin synthesis gene 
expression.  Hemolytic saponin accumulation in the foliar tissue of progeny of ESP105 x PRT178 
reciprocal crosses could be assayed to confirm what was found in A17 x ESP105 progeny, and saponin 
accumulation in root tissue of progeny of all cross types could be studied to identify the mechanisms 
responsible for differential root saponin accumulation in accessions. Cross progeny could be 
characterized using molecular markers located at regular distances along the chromosomes to identify 
quantitative trait loci (QTL) for saponin accumulation that could then be sequenced to discover candidate 
genes responsible for saponin synthesis regulation. Saponins possess many useful properties that make 
them attractive for applications in industry, agriculture, and human health and are valuable to the plants 
that produce them due to their activity against a wide variety of plant pests. Engineering of increased or 
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novel saponin synthesis in various plant species could be used to generate higher yields of commercially 
or medicinally important saponins or increase production of anti-pest saponins in economically important 
crops. The genes involved in saponin biosynthesis and the way those genes are regulated must be 
thoroughly understood before this engineering can be done. The economically important soybean plant 
produces soyasaponins and has orthologous genes to those involved in M. truncatula hemolytic saponin 
synthesis, but does not produce hemolytic saponins. The genes responsible for positive control of 
hemolytic saponin synthesis in M. truncatula would likely be key components necessary to engineering 





Cytotoxic activity of Medicago truncatula triterpene saponins 
 
Introduction 
When a pathogen attacks a plant, a complex cascade of signals is initiated that leads to the 
induction of the specialized metabolism of defense compounds that are specifically tailored to the type of 
pathogen involved (Pichersky and Lewinsohn, 2011). One family of specialized metabolites is the 
saponins, which are composed of a hydrophobic aglycone backbone and a polar sugar moiety. Saponins 
have been shown to have insecticidal, allelopathic, antiviral, antibacterial, nematicidal, and fungicidal 
properties that provide protection to the plants that produce them. The ability of saponins to permeabilize 
membranes imparts them with hemolytic activity and may also be partly responsible for saponin anti-pest 
properties (Augustin et al., 2011). Saponin-membrane interaction involves the spontaneous incorporation 
of saponins into the membrane outer layer driven by the attraction of the lipophilic aglycone to the lipid 
interior of the membrane (Lorent et al., 2014). Saponins then form 1:1 complexes with membrane sterols 
that aggregate to form plaques whose sterical nature results in membrane curvature, leading to the 
formation of pores that increase membrane permeability (Armah et al., 1999). In the case of erythrocytes, 
this pore formation can become severe enough to cause lysis of the cell. Various aspects of saponin 
structure and the type and concentration of cholesterol present in the membrane both affect saponin-
membrane interaction (Augustin et al., 2011; Moses et al., 2014a). Some saponins, including the 
triterpene soyasaponins in M. truncatula, do not demonstrate hemolytic activity as a result of structural 
characteristics (Yoshiki et al., 1998).  
Plants containing significant amounts of saponins have been used in the traditional medicines of 
many cultures for centuries, and in modern times research has shown that specific purified saponin 
compounds and crude saponin mixtures exhibit a variety of properties useful for improving human health 
(Güçlü-Üstündağ and Mazza, 2007). There has been substantial interest in the use of saponins as 
vaccine adjuvants, which are compounds used in combination with the antigens present in vaccines to 
increase immunity to those antigens. Saponins could be used in either traditional injection-administered 
vaccines or in orally administered vaccines as they have the ability to increase intestinal cell permeability 
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to facilitate the uptake of antigens. Orally administered vaccines are cheaper, easier, and less hazardous 
than injection-administered vaccines, and the intestinal infections that these vaccines could prevent are 
among the most common causes of mortality and morbidity in humans worldwide Francis et al., 2002). 
Quil A, isolated from Q. saponaria bark, and its derivative QS-21 have been used in experimental 
vaccines and vaccines in Phase I and II human trials (Sun et al., 2009). Saponins can prevent liver 
damage through a variety of mechanisms and are already being used to treat patients with hepatitis. The 
tritepene saponin glycyrrhizin, which is also the primary sweet-tasting component in licorice, is a primary 
component of Stronger Neo-Minophagen C (SNMC), a drug used in Japan to treat patients with hepatitis. 
The long term administration of SNMC was shown to reduce incidence of liver carcinogenesis in 
susceptible patients with chronic hepatitis C by suppressing inflammation (Arase et al., 1997). Oleanolic 
acid has been shown to decrease cirrhosis occurance in patients with liver diseases and return elevated 
aminotransferase activity in the serum to normal levels. It is currently used in China as an oral drug to 
treat acute and chronic hepatitis, as well as other liver disorders (Liu, 1995). Saponins have also been 
shown to have hypocholesterolemic, hypoglycemic, neuroprotective, and anti-inflammatory properties as 
well as activity against fungal, viral, and bacterial human pathogens and a therapeutic effect on the 
cardiovascular system (Francis et al., 2002; Lacaille-Dubois, 2007).  
However, most pertinent to this research is the ability of a variety of purfied saponins and crude 
saponin mixtures from multiple plant species to demonstrate cytotoxic activity against different cancer cell 
types in vitro and in vivo. The most obvious mechanism for this activity would seem to be pore formation 
resulting in necrosis through the same saponin-membrane interaction that causes hemolysis. Anticancer 
agents that cause necrosis are undesirable due to the resulting inflammation and adverse side effects 
(Bachran et al., 2008). Fortunately, the cytotoxic activity of saponins appears to be mediated through 
specific targeting of various cellular processes that is highly dependent on saponin structure and cancer 
cell type. Saponins have been reported to kill cancer cells and inhibit tumor growth through apoptosis 
induction, cell cycle arrest, autophagic cell death induction, angiogenesis inhibition, cytoskeleton 
disintegration, and metastasis inhbition (Podolak et al., 2010). For example, ardisiacrispin (A+B), a 
mixture of two tritepene saponins isolated from Ardisia crenata, was shown to decrease proliferation of 
Bel-7402 human hepatoma cells by induction of the intrinsic pathway of apoptosis through perturbation of 
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the mitochondrial membrane and by cytoskeleton disintegration through microtuble disassembly (Li et al., 
2008). Diosgenin, a steroid saponin found in fenugreek, inhibited Akt signaling, a pathway upregulated in 
many aggressive cancers, by downregulating pAkt gene expression and caused G1 cell cycle arrest by 
downregulating expression of specific cyclin and cyclin-dependent kinase genes in both estrogen receptor 
positive and negative breast cancer cells without significant toxicity to normal breast epithelial cells. 
These effects were verified in vivo; diosgenin significantly inhibited tumor growth in MCF-7 and MDA-231 
breast cancer xenograft nude mice (Srinivasan et al., 2009). Limited research exists on the safety of 
using saponins as chemotherapeutic drugs. A small portion of studies on the effects of saponins on 
cancer cells in vitro simultaneously test the effects of saponins on corresponding non-cancer cell lines, 
and the number of in vivo studies on saponin cytotoxicity is growing. The safety and tolerability of certain 
saponins has been studied in rodents and dogs, and saponins generally exhibit acceptable tolerability, 
especially at therapeutic concentrations (Weng et al., 2001). The most obvious point of concern when 
considering saponins as chemotherapeutic drugs is their hemolytic activity. This obstacle could be 
overcome by orally administering chemotherapeutic saponin drugs, as is done in many in vivo saponin 
cytotoxicity studies (Podolak et al., 2010). However, it is also important to consider that some cytotoxic 
saponins do not have hemolytic activity, and for the saponins that possess both properties, the saponin 
levels necessary for cytotoxic activity are lower than the levels necessary for hemolytic activity (Mimaki et 
al., 1998).  
Colorectal cancer is the third most common cancer and third leading cause of cancer death for 
both men and women in the United States (Omoyeni et al., 2015). While colorectal cancer is treatable, 
especially by surgical removal when diagnosed early, the current standard treatment used when 
metastasis has occurred, chemotherapy involving 5-fluorouracil and folinate in combination with 
radiotherapy, results in only a moderate decline in mortality, and risk of disease recurrance remains high 
(Tong et al., 2011). The Caco-2 cell culture line was originally derived from colorectal adenocarcinoma 
cells taken from a primary tumor in the colon of a 72-year-old Caucasian male and have been used to test 
the cytotoxicity of certain compounds against colon cancer cells (Lindl and Steubing, 2013). Saponins 
from G. trichophylla, P. pycnantha, and G. max have previously been shown to inhibit Caco-2 cell 
proliferation in vitro (Alam et al., 2015; Omoyeni et al., 2015; Salyer et al., 2013). The annual legume M. 
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truncatula is a close relative of alfalfa grown as winter forage in Australia and often used as a model 
legume in scientific research (Choi et al., 2004a). Commonly known as the barrel medic, M. truncatula 
produces two types of triterpene saponins, non-hemolytic soyasaponins derived from some of the same 
sapogenins produced by G. max and hemolytic saponins (Moses et al., 2014c). To the author’s 
knowledge, the effects of saponins derived from M. truncatula on cancer cells have not previously been 
studied. The M. truncatula species encompasses both commercial varieties that reflect the efforts of 
selective breeding and diverse native populations growing in the Mediterranean basin that reflect 
adaptation to the selective pressures of their unique environments. Four genetically distinct accessions 
that vary in the levels and types of saponins that they produce were used in this study, A17, derived from 
the commercial variety Jemalong, and ESP105, PRT178, and GRC43 isolated from the wild in Spain, 
Portugal, and Greece, respectively. Total saponins were extracted from the foliar tissue of the four 
accessions and analyzed by HPLC-MS to understand accession differences in saponin content that could 
explain differences in cytotoxic activity. The accession extracts were screened for cytotoxic activity 
against Caco-2 human colon cancer cells by measuring cell proliferation after treatment with extracts at 
various timepoints. To begin to understand the mechanism through which M. truncatula saponins induce 





Materials and Methods 
Plant maintenance 
 A17, ESP105, PRT178, and GRC43 seeds were scarified using the previously described 
procedure. The seeds were then thoroughly rinsed with distilled water and placed between two layers of 
moistened filter paper in a closed container. The container was placed in a dark cabinet for four days to 
allow for germination. Successfully germinated seedlings were then planted in Sunshine LC1 mix potting 
medium (SunGro Horticulture Distribution Inc., Bellevue, WA) and grown in a growth chamber at 22.5°C 
and 60% humidity with a 16:8 (light:dark) hour photoperiod. At 6- to 8-weeks of age, plants were moved 
to a greenhouse. Plants were watered, fertilized, and treated with a biological larvicide using the 
previously described procedures. Transplantation to larger pots occurred as needed. 
 
Saponin extraction 
A17, ESP105, PRT178, and GRC43 plants (11- to 13-weeks old) were subjected to mechanical 
damage three times across two days, at 4:00 p.m. on the first day and at 11:00 a.m. and 2:00 p.m. on the 
second day. Leaves were harvested the third day and stored at -80°C. After being freeze-dried for 48 
hours, leaves were pureed in 85% methanol at a ratio of 25 ml 85% methanol per 1 g leaf dry weight. 
Samples were mixed on a platform shaker for 3.5 hours at room temperature and then filtered through 
four layers of cheesecloth. The filtered extracts were centrifuged at 5000 RPM for 15 minutes to pellet out 
remaining leaf particles. Methanol was removed from the extracts through rotary evaporation. For crude 
purification, a Waters Sep-pak Vac 35cc C18 column was prewashed with two 7.5 ml volumes of 35% 
methanol and then loaded with 10 ml of extract diluted to a final concentration of 65% methanol. The 
column was washed with two 7.5 ml volumes each of water and 15% methanol, respectively, before 
eluting with four 7.5 ml volumes of 100% methanol. Extracts were dried using a stream of nitrogen gas, 
weighed, resuspended in 100% methanol to a concentration of 5 mg/ml, and stored at -20°C. 
 
High performance liquid chromatography/mass spectrometry 
A System Gold high performance liquid chromatograph (Beckman-Coulter, Fullerton, CA, USA) 
with autosampler (model 508), dual pump (model 126), photodiode array detector (model 168) with 
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Beckman-Coulter System 32 Karat software (version 8,2006) was used to analyze the saponin samples. 
The saponins were separated using a Phenomenex (Torrance, CA) Aqua 5µm C18 (250 × 4.6 mm) 
column and a binary gradient of 0.1% acetic acid for mobile phase A in water and 0.1% acetic acid in 
acetonitrile for mobile phase B at a flow rate of 0.8 mL/min. The gradient began isocratically from 0-10 
min at 1% B, then from 1 to 55% B from 10 to 110 min, from 55 to 100% B from 110 to 140 min, and from 
100 to 1% B at 141 min. Characteristic ions were used for peak assignment using HPLC/MS analysis. 
The HPLC/MS apparatus was interfaced to a Bruker Esquire LC/MS ion trap mass spectrometer. Mass 
spectral data were collected with the Bruker software, which also controlled the instrument and collected 
the signal at 200 to 400 nm. Conditions for mass spectral analysis in negative ion electrospray mode for 
flavonols included a capillary voltage of 4000 V, a nebulising pressure of 30.0 psi, a drying gas flow of 9.0 
ml min−1 and a temperature of 300°C. Data were collected in full scan mode over a mass range of m/z 
200–2000 at 1.0 s per cycle. Peak area was converted into mg hederagenin equivalents using an 
equation generated by running known amounts of a hederagenin standard.  
 
Preparation of saponin extracts for cell treatment 
 Extracts were placed under a thin stream of nitrogen gas to remove methanol. HPLC-MS 
quantification found varying mg hederagenin equivalents per g dried extract concentrations for the four 
accessions (Table 3). Because of the imprecision of using hederagenin as a standard for a mixture of 
saponins, the GRC43 saponin extract was quantified as having more than 1 g of saponins in 1 g of dried 
extract. To correct for this, all of the mg hederagenin equivalents per g dried extract concentrations were 
divided by the concentration of the GRC43 extract. Enough dried extract was then resuspended in 
dimethyl sulfoxide (DMSO) using the corrected mg hederagenin equivalents per g dried extract 







Table 3. Corrected saponin concentrations in crude extracts 
Accession mg Hederagenin Equivalents/g Dried 
Extract 
Corrected mg Hederagenin Equivalents/g 
Dried Extract 
GRC43 1103.44 1 
PRT178 993.07 899.98 
A17 768.46 696.42 




Caco-2 human colon cancer cells were obtained from the American Type Culture Collection 
(Manassas, Virginia) and maintained in Dulbecco’s modified Eagle’s medium containing 10% fetal bovine 
serum, 2% non-essential amino acids, and 1% antibiotic-antimycotic in a 75 cm3 flask at 37°C in a 
humidified 5% CO2 atmosphere. All media components were obtained from Gibco® through Life 
Technologies (Carlsbad, CA). Media in the flasks was changed every three to four days, and cells were 
passaged into two new flasks at 80% confluence, one to two times per week.  
 
Cell proliferation assay 
 Cells at passage numbers 21-33 were used for proliferation assays. Caco-2 cells in 100 µl of 10% 
fetal bovine serum media were seeded into the wells of four 96-well plates at a density of 2 x 103 cells per 
well and incubated at 37°C in a humidified 5% CO2 atmosphere. A serial dilution of cells (0-3.2 x 104) was 
also seeded in triplicate. After stable attachment (48 hrs), media was removed and replaced with 200 µl 
test media containing saponins extracted from A17, ESP105, PRT178, or GRC43 M. truncatula plants at 
a concentration of 100 µg/ml or 250 µg/ml, with a final DMSO concentration of 0.3%. Six wells were used 
per treatment type. For the negative control, three wells of cells were treated with 200 µl test media 
containing DMSO at a concentration of 0.3%. Three cell-free wells were also filled with 200 µl test media 
containing saponins or DMSO for each treatment type. Wells with serial dilution of cells were filled with 
200 µl of fresh media.  
 Cell proliferation was measured using the CellTiter 96® AQeuous One Solution Cell Proliferation 
Assay (Promega Corp. Madison, WI). Proliferation was measured at 2, 24, 48, and 72 hours post-
treatment. Assay reagent (40 µl) was directly added to all wells and incubated for 2 hours at 37°C in a 
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humidified 5% CO2 atmosphere before measuring absorbance at 490 nm. Absorbance of wells containing 
cells was corrected by subtracting the background absorbance of cell-free wells with the corresponding 
test media. Absorbance was then converted into cell numbers using a standard curve equation obtained 
by measuring the absorbance of wells containing the serial dilution of cells. The standard curve data for 
one of the three independent experiments is depicted in Figure 11.  
 
 
Figure 11. Standard curve for calculation of cell number. Data is from one of the three independent cell 
proliferation assays performed. Equation was used to convert absorbance readings of treatment wells into 





 Cells at passage numbers 35-38 were used for caspase-3 assays. Caspase-3 activity was 
measured using the Caspase-3 Fluorescence Assay Kit (Cayman Chemical Company, Ann Arbor, MI). 
Caco-2 cells in 100 µl of 10% fetal bovine serum media were seeded into the wells of a 96-well plate at a 
density of 3 x 104 cells per well and incubated at 37°C in a humidified 5% CO2 atmosphere. After stable 
attachment (48 hrs), media was removed and replaced with 200 µl test media containing saponins 
extracted from A17, ESP105, PRT178, or GRC43 M. truncatula plants at a concentration of 100 µg/ml, 
with a final DMSO concentration of 0.12%. For the negative control, cells were treated with test media 
containing DMSO at a concentration of 0.12%. Seven wells were used per treatment type. 
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 Caspase-3 activity was measured 48 hours post-treatment. The 96-well plate was centrifuged for 
5 min at 1000 rpm. Test media was removed and replaced with 200 µl of assay buffer, and the plate was 
centrifuged again for 5 min at 1000 rpm. The assay buffer was then removed and replaced with 100 µl 
lysis buffer. The plate was mixed on an orbital shaker at room temperature with gentle shaking for 30 min 
before being centrifuged for 10 min at 1000 rpm. The supernatant (90 µl) was then transferred to the 
corresponding wells of a black 96-well plate. Assay buffer (10 µl) was added to 6 wells per treatment type, 
while 10 µl of Caspase-3 inhibitor solution was added to the remaining well of each treatment type to 
verify substrate specificity. Active caspase-3 standard was serially diluted and 100 µl of each dilution was 
added to the plate. Caspase-3 substrate solution (100 µl) was then added to each well, and the plate was 
incubated for 30 min at 37°C in a humidified 5% CO2 atmosphere. The fluorescent intensity of each well 
was measured at 485 nm excitation and 528 nm emission. Fluorescence measurements were converted 
into caspase-3 U/well using an equation obtained from measuring the fluorescence of the serially diluted 
active caspase-3 standard (Figure 12).  
 
	  
Figure 12. Standard curve for calculation of caspase-3 U/well. Data is from one of the three independent 
caspase-3 activation assays performed. Equation was used to convert fluorescence readings of treatment 










 GraphPad Prism (GraphPad Software Inc., La Jolla, CA) was used to analyze cell proliferation 
and caspase-3 activation data. For cell proliferation data, means were compared to each other by one-
way ANOVA followed by Tukey’s multiple comparison tests between every possible pair of treatments 
and then compared to 100% by Student’s t test to assess significant difference from the solvent-treated 
control. Significance for all tests was defined as P<0.05. For caspase-3 activation data, treatment means 








M. truncatula accessions accumulate varying levels and types of saponins in leaf tissue 
 The four accessions of M. truncatula used in this study were chosen due to their natural variation 
in saponin accumulation profiles. Triterpene saponin levels in the roots and foliar tissue of many M. 
truncatula ecotypes, including the four accessions of interest (Table 4), have been described by metabolic 
profiling performed at the Samuel Roberts Noble Foundation (Lloyd Sumner, unpublished data).  
   
Table 4. Reported relative basal levels of triterpene saponins among accessions of M. truncatula 
 Tissue 
Accession Foliar Root 
A17 High High 
ESP105 Low Very High 
PRT178 High Intermediate 
GRC43 Very High Low 
Table 4. Reported relative basal levels of triterpene saponins among accessions of M. truncatula. Values 
are based on unpublished metabolic profiles (Lloyd Sumner and David Huhman, Samuel Roberts Noble 




	   Saponin profiles of foliar tissue from the four accessions of interest were investigated by HPLC 
mass spectrometry to allow for accurate saponin concentration values for cell culture treatments and 
information that could explain differences in cytotoxicity among accession treatments. Known amounts of 
a hederagenin standard were also analyzed to create a standard curve for converting area under the 
curve for peaks from the crude extract analysis into mg hederagenin equivalents. The amounts of 
saponins in the crude extracts are reported as mg hederagenin equivalents per g dried extract.  
Extracts from A17, ESP105, PRT178, and GRC43 foliar tissue contained varying levels of total 
saponins. Because saponins were not extracted with an internal standard, some variation may be a result 
of error in the extraction process and not a true reflection of saponin accumulation levels in foliar tissue. 
However, total saponin levels roughly agreed with the relative levels previously reported (Table 4); 
GRC43 extracts had the highest concentration of saponins, while A17 and PRT178 extracts had lower 
levels of saponins but maintained higher saponin concentrations than ESP105, which had the lowest 
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concentration of saponins. Because hederagenin is not a perfect standard for the quantification of a 
mixture of different saponins, GRC43 extracts were characterized as having more than 1 g of saponins in 
1 g of dried extract. This was accounted for in preparation of cell culture treatments, as described in 
Materials and Methods.  
 
	  
Figure 13. Saponin profiles in M. truncatula accessions. Sapogenin accumulation levels in extracts from 
mechanically damaged M. truncatula A17, ESP105, PRT178, and GRC43 leaf tissue were quantified by 




Saponin amounts for the most abundant sapogenins were pooled and compared in Figure 13 and 
Table 5. The most abundant sapogenin in both GRC43 and PRT178 extracts was soyasapogenol B, 
while the most abundant sapogenin in A17 and ESP105 extracts was bayogenin. The second most 
abundant sapogenin in the GRC43 extract was an unknown sapogenin labeled as aglycone 1, followed 
by fairly similar amounts of the hemolytic sapogenins, hederagenin, bayogenin, and medicagenic and 
zanhic acid, and then low levels of soyasapogenol E and unknown aglycone 2. The second most 
abundant sapogenin in the PRT178 extract was hederagenin, closely followed by zanhic acid and then 
bayogenin and medicagenic acid. Unknown aglycone 1, soysasapogenol E, and unknown aglycone 3 
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were detected at low levels. The second most abundant sapogenin in the A17 extract was soyasapogenol 
B, followed by hederagenin, and then roughly equivalent amounts of unknown aglycone 1, 
soyasapogenol E, and medicagenic and zanhic acid. Low levels of unknown aglycone 2 and 3 were 
detected. The second most abundant sapogenin in the ESP105 extract was hederagenin, followed by an 
almost equal amount of soyasapogenol B, intermediate amounts of zanhic acid, unknown aglycone 3, 
soyasapogenol E, and unknown aglycone 2, and low levels of unknown aglycone 1 and medicagenic 
acid. In general, the accession extracts contained a higher proportion of hemolytic sapogenins than 
soyasapogenins and high levels of soyasapogenol B, hedergenin, and bayogenin, intermediate levels of 
medicagenic and zanhic acid, and low levels of soyasapogenol E and unknown aglycones. Exceptions 
include the high proportion of unknown aglycone 1 in GRC43 and zanhic acid in PRT178 and the low 
proportion of medicagenic acid in ESP105. 
	   	  
Table 5. Sapogenin amounts in M. truncatula accessions as a percent of total saponins 
 % of total saponins 
Sapogenin A17 ESP105 PRT178 GRC43 
Unknown aglycone 1 9.42 4.01 5.58 16.14 
Unknown aglycone 2 2.05 6.17 n.d. 1.55 
Unknown aglycone 3 4.27 7.25 1.33 n.d. 
Soyasapogenol B 18.04 20.14 26.64 22.77 
Soyasapogenol E 9.50 6.77 0.45 6.35 
Hederagenin 16.44 20.34 18.06 14.01 
Bayogenin 24.63 22.02 14.99 15.05 
Medicagenic acid 7.79 2.58 11.83 12.13 
Zanhic acid 7.86 10.71 17.73 9.87 
Table 5. Sapogenin amounts in M. truncatula accessions as a percent of total saponins. Crude saponin 
extracts from A17, ESP105, PRT178, and GRC43 foliar tissue were analyzed using HPLC-MS. Saponin 





 Individual saponin components of the extracts were identified and quantified by HPLC-MS (Table 
6). Most of the glycosidically attached sugar constituents were characterized as unspecified hexose 
sugars. However, pentose, galactose, glucose, galacturonic acid, rhamnose, arabinose, apiofuranose, 
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and xylose attachments were more specifically identified as modifying multiple sapogenin backbones. 
Many saponins were uniquely identified in only one accession extract. The A17 extract was the most 
diverse with 39 different saponins identified and eight of those unique to A17, while the ESP105 extract 
was the least diverse with only 21 different saponins. 3-Glc-medicagenic acid and dHex-hex-HexA-
soyasapogenol B were the only saponins uniquely identified in the ESP105 extract. The PRT178 extract 
contained 30 different saponins, including six unique to PRT178, and the GRC43 extract contained 32 
saponins, including eight unique to GRC43. Only seven saponins were present in all four accessions: 
dHex-Hex-Hex-HexA-soyasapogenol B, 3-Rha-Gal-GlcA-soyasapogenol B, 3-Rha-Xyl-GlcA-
soyasapogenol B, Malonyl-Hex-Hex-HexA-soyasapogenol E, Hex-bayogenin, 3-Glc-Glc-28-Ara-Rha-Xyl-
Api-zanhic acid, and 3-Glc-28-Ara-Rha-Xyl-zanhic acid. One of those saponins, dHex-Hex-Hex-HexA-
soyasapogenol B, was also the most abundant saponin detected in the A17, PRT178, and GRC43 
extracts. The most abundant saponin in the ESP105 extracts was Hex-dHex-Hex-HexA-hederagenin.  
 
Table 6. Mass spectral identification of saponins 
 mg hederagenin equivalents/g dried extract 
Saponin A17 ESP105 PRT178 GRC43 
Hex-Hex-HexA-unknown aglycone 1 15.27 n.d. 54.62 81.09 
Hex-HexA-unknown aglycone 1 36.56 n.d. 0.83 22.29 
Malonyl-Hex-Hex-HexA-unknown aglycone 1 7.57 n.d. n.d. 36.98 
Hex-HexA-Malonyl-unknown aglycone 1 n.d. 25.33 n.d. 37.78 
Malonyl-Hex-Hex-Hex-HexA-unknown aglycone 1 12.98 n.d. n.d. n.d. 
dHex-Hex-HexA-unknown aglycone 2 15.75 38.93 n.d. 17.06 
Hex-Hex-unknown aglycone 3 32.79 19.23 n.d. n.d. 
Hex-unknown aglycone 3 n.d. 26.53 13.20 n.d. 
Pen-Hex-Hex-unknown aglycone 4 n.d. n.d. 33.70 n.d. 
Hex-Hex-unknown aglycone 5 n.d. n.d. n.d. 6.99 
dHex-Hex-Hex-HexA-soyasapogenol B 65.26 34.22 158.58 118.02 
3-Rha-Gal-GlcA-soyasapogenol B 23.36 18.74 73.80 73.26 
3-Rha-Xyl-GlcA-soyasapogenol B 25.30 17.01 2.55 30.22 
Pen-Hex-HexA soyasapogenol B 10.79 n.d. 29.61 n.d. 
Malonyl-dHex-Hex-HexA-soyasapogenol B 13.95 n.d. n.d. 4.11 
dHex-hex-HexA-soyasapogenol B n.d. 57.08 n.d. n.d. 
Malonyl-Hex-Hex-HexA-soyasapogenol B n.d. n.d. n.d. 25.58 
dHex-Hex-HexA-soyasapogenol A n.d. n.d. n.d. 16.58 
Malonyl-Hex-Hex-HexA-soyasapogenol E 18.99 18.86 3.98 19.62 
3-Rha-Gal-GlcA-soyasapogenol E n.d. 23.87 n.d. 50.42 
Rha-Hex-Hex-soyasapogenol E 12.09 n.d. n.d. n.d. 
Hex-Hex-HexA-soyasapogenol E 24.98 n.d. n.d. n.d. 
Hex-HexA-soyasapogenol E 16.94 n.d. n.d. n.d. 
Hex-dHex-Hex-HexA-soyasapogenol E n.d. n.d. 0.44 n.d. 
dHex-Hex-Hex-hederagenin 20.96 20.06 63.04 n.d. 
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Table 6. (Cont.) 
 mg hederagenin equivalents/g dried extract 
Saponin A17 ESP105 PRT178 GRC43 
Hex-Hex-HexA-hederagenin 13.39 43.31 n.d. 65.90 
Malonyl-Hex-Hex-HexA-hederagenin 39.90 n.d. 24.75 51.36 
dHex-Hex-HexA-hederagenin 30.25 n.d. 16.71 n.d. 
dHex-Hex-Hex-Hex-hederagenin 21.85 n.d. 36.26 n.d. 
Hex-dHex-Hex-HexA-hederagenin n.d. 64.97 18.28 n.d. 
Malonyl-Hex-HexA-hederagenin n.d. n.d. 20.33 n.d. 
Ara-Glc-Ara-hederagenin n.d. n.d. n.d. 15.50 
Malonyl-Hex-Malonyl-Hex-hederagenin n.d. n.d. n.d. 21.87 
Hex-bayogenin 26.42 25.11 31.63 19.33 
dHex-Hex-HexA-bayogenin 13.35 55.14 66.49 n.d. 
Hex-Hex-bayogenin 56.30 25.95 n.d. 62.63 
Hex-dHex-Hex-Hex-bayogenin 17.51 32.74 n.d. 33.10 
Hex-HexA-bayogenin 16.98 n.d. 23.11 n.d. 
Hex-Hex-Rha-bayogenin 18.41 n.d. 27.59 n.d. 
Malonyl-Hex-HexA-bayogenin 6.97 n.d. n.d. 26.26 
Malonyl-Hex-bayogenin 11.55 n.d. n.d. n.d. 
Malonyl-Hex-Hex-HexA-bayogenin  21.79 n.d. n.d. n.d. 
Hex-Hex-HexA-bayogenin n.d. n.d. n.d. 24.76 
3-Glc-Glc-28-Ara-Rha-Xyl-medicagenic acid 7.67 n.d. 18.52 60.85 
3-Glc-Glc-Rha-28-Glc-medicagenic acid 8.67 n.d. 15.41 n.d. 
3-GlcA-28-Ara-Rha-Xyl-medicagenic acid 35.05 n.d. n.d. 6.70 
3-Glc-28-Ara-Rha-Xyl-medicagenic acid 8.45 n.d. n.d. 15.45 
3-Glc-medicagenic acid n.d. 16.29 n.d. n.d. 
Malonyl-Hex-Malonyl-Hex-medicagenic acid n.d. n.d. 56.77 n.d. 
3-GlcA-28-Glc-medicagenic acid n.d. n.d. 26.75 n.d. 
3-Glc-Glc-medicagenic acid n.d. n.d. n.d. 18.76 
Malonyl-Hex-Hex-medicagenic acid n.d. n.d. n.d. 32.07 
3-Glc-Glc-28-Ara-Rha-Xyl-Api-zanhic acid 8.24 32.84 54.54 25.93 
3-Glc-28-Ara-Rha-Xyl-zanhic acid 7.54 16.57 33.11 33.72 
3-Glc-Glc-28-Ara-Rha-Xyl-Ara-zanhic acid 32.69 n.d. 35.25 24.60 
3-Glc-Glc-28-Ara-Rha-Api-zanhic acid 7.68 n.d. 20.09 24.62 
3-Glc-Glc-28-Ara-Rha-Ara-zanhic acid n.d. 18.16 22.07 n.d. 
3-Glc-Glc-Glc-23-Ara-28-Ara-Rha-Xyl- zanhic acid 4.28 n.d. n.d. n.d. 
3-Glc-Glc-28-Ara-Rha-Xyl-zanhic acid n.d. n.d. 11.05 n.d. 
     
Total 768.46 630.92 993.07 1103.44 
Table 6. Mass spectral identification of saponins. Crude saponin extracts from A17, ESP105, PRT178, 
and GRC43 foliar tissue were analyzed by HPLC-MS. Concentrations were calculated using a standard 
curve obtained by running known amounts of a hederagenin standard. Abbreviations: Api, apiofuranose; 
Ara, arabinose; dHex, 6-deoxyhexose such as rhamnose or furanose; Gal, galactose; Glc, glucose; GlcA, 
galacturonic acid; Hex, hexose such as glucose or galactose; HexA, uronic acid such as glucuronic acid 









Treatment with M. truncatula saponin extracts results in decreased Caco-2 cell proliferation 
 Caco-2 cell cultures were treated with crude saponin extracts from the four M. truncatula 
accessions at a concentration of 100 or 250 µg/ml final concentration. Percent viability was calculated by 
measuring the number of live cells present at 2, 24, 48, and 72 hours post-treatment and comparing to 
the solvent-treated control at the corresponding time point. The mean percent viability for three 
independent experiments with six replicates each (n=18) was calculated for each treatment.  
 
	  
Figure 14. Percent cell viability for Caco-2 cells treated with A17, ESP105, PRT178, and GRC43 
saponin extracts at 100 µg/ml 10% FBS media. Values are means ± SEM (n=18), as compared to 
solvent-treated cultures. Means were compared to each other by one-way ANOVA followed by Tukey’s 
multiple comparison tests. Means marked with different letters at 72 hr are significantly different 
(P<0.05). Means were also compared to 100% by Student’s t test. By 72 hr, all extracts caused 




Treatment with saponin extracts from all four M. truncatula accessions at 100 µg/ml concentration 
resulted in significantly decreased Caco-2 cell proliferation compared to the solvent-treated control by 72 
hr (P<0.05)(Figure 14). The earliest time point tested was 2 hr, which reflects the minimum timespan 
necessary for treatment of the cultures and conducting the assay. At 2 hr post-treatment, only A17 
extracts significantly decreased cell proliferation as compared to the control (80.0%)(P=0.025). Apparent 
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differences at this time point are more likely a result of inconsistencies in cell seeding number than an 
actual effect of treatments, due to the difficulty of achieving uniformity when dealing with live cells. After a 
slight increase in cell viability at 24 hr, treatment with ESP105 and PRT178 extracts resulted in 
significantly decreased cell proliferation as compared to the solvent-treated control at 48 hr (P<0.01), 77.0 
and 85.5% viability, respectively, and by 72 hr all extracts had significantly reduced cell viability as 
compared to the solvent-treated control, A17 to 66.7%, ESP105 to 56.6%, PRT178 to 79.1%, and GRC43 
to 87.1% (P<0.05). ESP105 extract had a significantly stronger effect than GRC43 on Caco-2 cell 
proliferation by 72 hr (P<0.01).  
 
	  
Figure 15. Percent cell viability for Caco-2 cells treated with A17, ESP105, PRT178, and GRC43 
saponin extracts at 250 µg/ml 10% FBS media. Values are means ± SEM (n=18), as compared to 
solvent-treated cultures. Means were compared to each other by one-way ANOVA followed by Tukey’s 
multiple comparison tests. Means marked with different letters at 72 hr are significantly different 
(P<0.05). Means were also compared to 100% by Student’s t test. All extracts at all time points, except 




 Treatment with saponin extracts from all four M. truncatula accessions at 250 µg/ml resulted in 
significantly decreased levels of Caco-2 cell proliferation compared to the solvent-treated control for all 
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time points and treatments except GRC43 treatment at 72 hr (P<0.05) (Figure 15). At 2 hr, all extracts 
significantly decreased percent cell viability, A17 to 71.1%, ESP105 to 55.8%, PRT178 to 64.5%, and 
GRC43 to 59.6% (P<0.0001). By 24 hr, ESP105 extracts had a significantly stronger effect (29.7% 
viability) on Caco-2 cell proliferation than A17 (60.3%) and PRT178 (82.4%) extracts (P<0.05), but not 
GRC43 (58.7%) extracts. However, by 48 hr, cell viability under GRC43 treatment rose to 61.1%, 
continued to rise to 72.3% 72 hr post-treatment, and was no longer significantly different from the 100% 
cell viability of the solvent-treated control. Cell viability under PRT178 treatment moderately declined to 
66.1% at 48 hr and then slightly increased to 69.2% at 72 hr. Treatment with A17 and ESP105 extracts 
resulted in a decrease in cell viability at 48 hr, 45.9 and 20.1% respectively, with ESP105 extracts having 
a significantly stronger effect than PRT178 and GRC43 extracts (P<0.001). This trend continued at 72 hr, 
with A17 and ESP105 extracts resulting in a decrease in cell viability to 23.2 and 9.3% respectively. At 72 
hr, both A17 and ESP105 extracts had a significantly stronger impact on Caco-2 cell proliferation than 
PRT178 and GRC43 extracts (P<0.001).  
 Treatment with A17, ESP105, PRT178, and GRC43 saponin extracts decreased Caco-2 cell 
proliferation in a time and dose-dependent manner. The 250 µg/ml treatment had a greater effect on cell 
proliferation than the 100 µg/ml treatment of extracts from all four accessions. Under 100 µg/ml treatment, 
cell viability increased until 24 hr, and the treatments did not result in decreased cell proliferation until 48 
hr. Under 250 µg/ml treatment, the four accession treatments all initially decreased cell proliferation at 2 
hr, but treatment with A17 and ESP105 extracts resulted in a continuing trend of decreasing percent cell 
viability until 72 hr, while cell viability under treatment with PRT178 and GRC43 extracts was more erratic 
and seemed to eventually overcome treatment, increasing slightly from 48 to 72 hr. At both 
concentrations, the ESP105 extract had the strongest effect on Caco-2 cell proliferation, followed by the 
A17, then PRT178, and finally GRC43 extracts.  
 
Treatment with M. truncatula saponin extracts does not result in increased activation of caspase-3 
 Many saponins that have been shown to decrease cancer cell proliferation do so through the 
induction of apoptosis (Bachran et al., 2008; Podolak et al., 2010). Caspase-3 is an enzyme essential to 
the execution phase of apoptosis that can be activated by either the extrinsic or intrinsic pathway and has 
	  
 76	  
been shown to be mutated in multiple cancers (Ghavami et al., 2009). Caco-2 cell cultures seeded in a 
96-well plate were treated with crude saponin extracts from the four M. truncatula accessions at a 
concentration of 100 µg/ml. After 48 hours, cells were lysed and the amount of active caspase-3 present 
was measured. The mean caspase-3 U/well for three independent experiments with three or six 




Figure 16. Active caspase-3 (U/well) in Caco-2 cells treated with A17, ESP105, PRT178, and GRC43 
saponin extracts at 100 µg/ml in 10% FBS media for 48 hr. Control was treated with solvent. Values are 





 Treatment with saponin extracts from all four M. truncatula accessions at 100 µg/ml did not result 
in significantly increased levels of active caspase-3 compared to the solvent-treated control (P<0.05) 
(Figure 16). The mean amount of active caspase-3 ranged from 0.011 to 0.013 U/well. The amount of 
active caspase-3 in wells treated with ESP105, PRT178, and GRC43 extracts was not significantly 
different from the solvent-treated control. A17 treatment resulted in a significantly different, but 





Saponins have been shown to possess a variety of properties that could benefit human health, 
including neuroprotective, hypoglycemic, hepatoprotective, cytotoxic, hypocholesterolemic, and 
immunostimulatory activities, as well as therapeutic effects on the cardiovascular system and activity 
against viral, fungal, and bacterial human pathogens (Francis et al., 2002; Lacaille-Dubois, 2007). Many 
of these beneficial effects of saponins can be obtained through consumption of saponin-rich foods or oral 
administration of saponin supplements. A supplement called Cholestaid™ containing 900 mg of saponin-
rich M. sativa extract and 100 mg citric acid that claims to “neutralize” cholesterol in the stomach and 
facilitate its excretion has been made available in the United States (Bora and Sharma, 2011). Mice who 
were fed a high-fat diet supplemented with a saponin-rich petroleum ether Y. schidigera extract 
demonstrated improved hormone levels, lipid profile, and biochemical parameters compared to mice that 
were fed an unsupplemented high-fat diet, indicating that Y. schidigera extracts could be used as 
preventative medicine in nutritional disorders such as obesity (Kucukkurt et al., 2016). Commercial 
saponin products, including a soybean concentrate and a Korean ginseng extract called saponia, have 
been marketed as functional food products and nutraceuticals, and a method has been developed for 
fortifying food products, such as olive oil, with oleanolic acid due to its presumed health benefits (Güçlü-
Üstündağ and Mazza, 2007). Frequent consumption of soybeans and soybean-based products is 
correlated with reduced cancer incidence, especially for colon cancer, and this may be due to their 
relatively high saponin content (Li et al., 2015). Soybean-derived saponins have been shown to have 
cytotoxic activity in multiple studies (Ellington et al., 2005; Gurfinkel and Rao, 2003; Kim et al., 2004; Oh 
and Sung, 2001; Salyer et al., 2013). 
Saponins from a variety of plant sources in the form of purified compounds and crude mixtures 
have been reported as having cytotoxic activity against a variety of cancer cell types. This effect is 
mediated through a variety of complex mechanisms dependent on both saponin structure and cancer cell 
type (Bachran et al., 2008; Podolak et al., 2010). M. truncatula, an annual legume, accumulates saponins 
in foliar tissue constitutively and in response to herbivory as a means of plant defense (Huhman and 
Sumner, 2002; Gholami et al., 2014). The M. truncatula accessions A17, ESP105, PRT178, and GRC43 
have originated from different locations and circumstances and accumulate different levels and types of 
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saponins as a result of selective breeding or adaptation to the unique challenges of their environments 
(Delalande et al., 2007; Rogers, 2015). We hypothesized that crude mixtures of saponins extracted from 
the four M. truncatula accessions would differentially exhibit cytotoxicity activity against Caco-2 human 
colon cancer cells grown in culture. M. truncatula crude saponin extracts significantly decreased Caco-2 
cell proliferation when administered at a final concentration of both 100 and 250 µg/ml. Extract from 
ESP105 foliar tissue exhibited the strongest effect on cell proliferation, followed by A17, PRT178, and 
GRC43 extracts, respectively.  
Crude saponin extracts from A17, ESP105, PRT178, and GRC43 foliar tissue were analyzed by 
HPLC-MS. The concentration of pure saponins in the extracts was quantified to allow for treatment of cell 
cultures with an accurately measured amount of saponins that was equal across the four accession 
treatments. Individual saponins within the mixture were putatively identified to provide information on 
saponins that may primarily contribute to cytotoxicity of the extracts and could be candidates for further 
purification and study. Glycosides of 12 different sapogenin backbones were detected. Soyasapogenol B 
and E, hederagenin, bayogenin, and medicagenic and zanhic acid have been reported as being present 
in M. truncatula foliar tissue (Huhman and Sumner, 2002; Kapusta et al., 2005a), while the unknown 
sapogenins labeled as aglycone 1-2 and 4-5 and soyasapogenol A have only previously been detected in 
M. truncatula hairy roots	  (Pollier et al., 2011a). Aglycones 1 and 4 (referred to as Aglycones A and B by 
Pollier et al.) have been tentatively identified as 2β,3β-dihydroxy-23-oxo-olean-12-en-28-oic acid and 
gypsogenin (2011a). The backbone 2β,3β-dihydroxy-23-oxo-olean-12-en-28-oic acid is proposed to be a 
biosynthetic intermediate resulting from the oxidation of bayogenin at the C-23 position, which is then 
itself oxidized at the same position to form medicagenic acid (Tava et al., 2011). Glycosides of 2β,3β-
dihydroxy-23-oxo-olean-12-en-28-oic acid have been isolated from roots of M. hybrida and leaves of M. 
arborea and M. arabica (Bialy et al., 2006; Tava et al., 2005; Tava et al., 2009). Gypsogenin has been 
proposed as a biosynthetic intermediate resulting from oxidation of hederagenin at the C-23 position, 
which is then itself oxidized at the C-2 position to form 2β,3β-dihydroxy-23-oxo-olean-12-en-28-oic acid 
(Gholami et al., 2014). A glycoside of gypsogenin was detected in the root tips and border cells of M. 
truncatula A17 plants (Watson et al., 2015). The structures of aglycones 2 and 5 (referred to as 
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Aglycones D and C by Pollier et al.) could not be determined, but their calculated molecular formulas are 
C30H44O6 and C30H50O5, respectively (2011a). Unknown aglycone 3 has not previously been identified.  
The most abundant sapogenin in A17 and ESP105 plants was bayogenin, while the most 
abundant sapogenin in PRT178 and GRC43 plants was soyasapogenol B (Table 5). In general, 
soyasapogenol B, hederagenin, and bayogenin were the major components of the extracts and 
medicagenic and zanhic acid were present at slightly smaller but still sizable proportions. Unknown 
aglycones 1-5 and soyasapogenol A and E were generally minor components of the extracts. Notable 
exceptions include the relatively high proportion of zanhic acid and unknown aglycone 1 in PRT178 and 
GRC43 extracts, respectively, and the relatively low proportion of medicagenic acid in ESP105 extracts. 
This disagrees with the existing literature, which reports that glycosides of medicagenic acid are the 
primary group of saponins accumulating in M. truncatula A17 foliar tissue and that glycosides of 
hederagenin and bayogenin are only present as trace amounts (.3-2.9%)(Huhman et al., 2005; Kapusta 
et al., 2005a; Tava and Pecetti, 2012).  However, on the amounts of other sapogenins in A17 foliar tissue, 
there is disagreement within the existing literature. Tava and Pecetti (2012) and Huhman et al. (2005) 
found that soyasapogenol B glycosides accounted for 17 and 25.8% of total saponins, while Kapusta et 
al. (2005a) reported soyasapogenol B glycosides as present in only trace amounts (1.3%). The three 
sources also vary widely on the amount of zanhic acid glycosides present in saponin mixtures; Huhman 
et al. (2005) report .6%, while Tava and Pecetti (2012) report 13.5% and Kapusta et al. (2005a) report 
42.1%. These discrepancies could stem from the use of different standards and different numbers of 
standards to quantify saponins. This study used a single hederagenin standard to quantify a chemically 
complex mixture of saponins, while Kapusta et al. (2005a) used 18 saponins with one of four different 
backbone structures as standards. The age and conditions of the plants used in the four studies also 
differed with some being grown in the field and others being grown in a greenhouse, as in this study. A 
disproportionate amount of certain sapogenins could also reflect an affinity bias of the column used in the 
extraction process.  
Glycosylation of M. truncatula triterpene saponins occurs primarily at the C-3 and C-28 positions 
and rarely at the C-23 position and can involve apifuranose, arabinose, galactose, glucose, galacturonic 
acid, pentose, rhamnose, and xylose constituents (Gholami et al., 2014; Huhman et al., 2005). Non-
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hemolytic soyasaponins are monodesmosidic, while hemolytic saponins can be mono-, bi- or tri-
desmosidic (Tava et al., 2011). Attached sugar chains can be modified by the presence of malonyl groups 
(Huhman et al., 2005; Pollier et al., 2011a). Individual saponin components were identified and quantified 
by mass spectrometry (Table 6). Soysaponins glycosylated at the C-3 position and hemolytic saponins 
glycosylated at the C-3, C-28, and/or C-23 were detected. The majority of sugar chain constituents were 
reported as hexose because exact stereochemistry of the sugar could not be determined. All chemically 
characterized sugar constituents detected have been observed attached to sapogenin backbones.  
Malonyl modification of sugar chains was also detected. A17 extracts were the most diverse, with 39 
different saponins, followed by GRC43 with 32, PRT178 with 30, and ESP105 with 21. 52 of the 59 
saponins detected have been previously reported in extracts from various M. truncatula organs (Huhman 
et al., 2005; Huhman and Sumner, 2002; Kapusta et al., 2005a; Pollier et al., 2011a). Malonyl-Hex-Hex-
Hex-HexA-unknown aglycone 1, Hex-Hex-unknown aglycone 3, Hex-unknown aglycone 3, dHex-hex-
HexA-soyasapogenol B, Malonyl-Hex-Hex-HexA-soyasapogenol B, dHex-Hex-Hex-Hex-hederagenin, 
and 3-Glc-Glc-28-Ara-Rha-Xyl-Api-zanhic acid have not previously been reported in M. truncatula 
saponin extracts to the author’s knowledge. Of the seven novel saponins, three were only detected here 
in extracts of M. truncatula accessions that have not yet been chemically investigated in the literature, 
Hex-unknown aglycone 3 in ESP105 and PRT178, dHex-hex-HexA-soyasapogenol B in ESP105, and 
Malonyl-Hex-Hex-HexA-soyasapogenol B in GRC43, and could be uniquely produced in those 
accessions.  
Extracts from A17, ESP105, PRT178 and GRC43 foliar tissue at the final concentrations of 100 
and 250 µg/ml significantly decreased Caco-2 cell proliferation in a time-dependent manner (Figure 14 
and 15). To the author’s knowledge, the effects of saponin extracts from M. truncatula on cancer cells 
have not previously been studied. Saponins purified from M. sativa inhibited the growth of the K562 
human leukemia cell line in vitro (Tava and Odoardi, 1996). Soyasaponin I isolated from Glycine max 
decreased Caco-2 cell proliferation and reduced activity of the proliferation enzyme protein kinase C 
(Salyer et al., 2013). Soyasponin I, referred to in Table 6 as 3-Rha-Gal-GlcA-soyasapogenol B, is also 
produced by M. truncatula and was detected in extracts from all four accessions. At both treatment 
concentrations, ESP105 extracts had the strongest effect on Caco-2 cell proliferation, followed by A17, 
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PRT178, and GRC43 extracts, respectively. The differences in extract effectiveness could be due to 
differences in the concentration of total saponins present in crude extracts. Total saponins were 
quantified using HPLC-MS and reported as mg hederagenin equivalents per g dried crude extract. An 
amount of dried crude extract necessary to obtain the desired amount of total saponins, equal across the 
accessions, was then dissolved in DMSO for cell culture treatments. Because GRC43 total saponins were 
almost twice as concentrated as ESP105 total saponins, approximately half as much GRC43 dried crude 
extract was needed compared to ESP105 dried crude extract to obtain an equal amount of total saponins. 
The order of the accessions organized by cytotoxicity effect from strong to weak (ESP105, A17, PRT178, 
GRC43) is the same as the order of the accessions organized by concentration of total saponins in crude 
extracts from lowest to highest. Compounds in the non-saponin portion of the dried crude extracts were 
not identified. It is possible that the greater proportion of unidentified compounds present in ESP105 and 
A17 treatments could have contributed to their greater effect on Caco-2 cell proliferation.   
However, differences in the composition of accession extracts could also explain the differences 
in cytotoxic effect. The most abundant aglycone backbone in the more cytotoxic A17 and ESP105 
extracts was bayogenin, while the most abundant aglycone backbone in the less cytotoxic PRT178 and 
GRC43 extracts was soyasapogenol B. The most abundant saponin in the ESP105 extract was Hex-
dHex-Hex-HexA-hederagenin, while the most abundant saponin in the other accession extracts was 
dHex-Hex-Hex-HexA-soyasapogenol B. Two saponins were uniquely detected in the ESP105 extracts, 3-
Glc-medicagenic acid and dHex-hex-HexA-soyasapogenol B. While the amount of 3-Glc-medicagenic 
acid was relatively low in the ESP105 extract, dHex-hex-HexA-soyasapogenol B was the second most 
abundant saponin. The saponins Hex-dHex-Hex-HexA-hederagenin and dHex-hex-HexA-soyasapogenol 
B may be important contributors to the comparatively higher cytotoxic effect of the ESP105 extract. 
Oleanane-type saponins with a free carboxylic group at the C-28 position have been shown to have a 
stronger cytotoxic effect on four human solid tumor cell lines when compared to oleanane-type saponins 
with sugars attached at the C-28 position (Bang et al., 2005). The proportion of total saponins with a free 
carboxylic group at the C-28 position (all glycosides of unknown aglycone 1 and 4, bayogenin, and 
hederagenin and four glycosides of medicagenic acid) was approximately equal in A17, ESP105, and 
GRC43 extracts (48.96-50.49%) but slightly lower in PRT178 extracts (38.57%). More generally, certain 
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monodesmosidic saponins have been shown to have a stronger cytotoxic effect than bidesmosidic 
saponins. Monodesmosidic saponins showed higher cytotoxic activity than bidesmosides in a study of the 
cytotoxic effects of 16 triterpene saponins extracted from Hedera helix, Calendula arvensis, Calendula 
officinalis, and Sapindus mukurossi on HeLa cells (Quetin-Leclercq et al., 1992). ESP105 extracts have 
the highest proportion of monodesmosidic saponins with 89.32%, followed by A17, GRC43, and PRT178 
extracts with 84.35, 82.61, and 76.16%, respectively. These findings might help to explain why ESP105 
saponin extracts have the strongest negative impact on Caco-2 cells in this study.  The relatively low 
amount of glycosides of unknown aglycones 2-5 and soyasapogenol A in all extracts and the low amount 
of medicagenic acid glycosides in the ESP105 extract suggests that these saponins are not important 
contributors to the cytotoxic effect of the extracts. 
To investigate the mechanism by which M. truncatula saponin extracts decrease Caco-2 cell 
proliferation, caspase-3 activation in response to saponin treatment was studied. The majority of saponins 
that have been shown to kill cancer cells do so through the induction of apoptosis (Bachran et al., 2008), 
and caspase-3 is an enzyme activated by both the intrinsic and extrinsic pathway of apoptosis (Ghavami 
et al., 2009). Apoptosis induction by saponin treatment has previously been shown in Caco-2 cells by 
assays that assess differential membrane composition in apoptotic cells and caspase 3/7 and 9 activation 
and by DAPI staining (Alam et al., 2015; Omoyeni et al., 2015). Apoptosis induction in Caco-2 cells 
treated with the well-established antitumor agent butyrate did not begin until 16 hr after treatment and had 
occurred in 60% of cells by 48 hr (Ruemmele et al., 2003). After treatment with M. truncatula saponin 
extracts at 100 µg/ml, Caco-2 cell proliferation did not begin to decline until 48 hr post-treatment. 
Apoptosis induction caused by treatment with saponin extracts from the four accessions at 100 µg/ml was 
evaluated in three independent experiments by assaying caspase-3 activation at 48 hr post-treatment, 
and no effect was found (Figure 16). Single experiments assaying caspase-3 activation 24 hr after 100 
µg/ml treatments from the four accessions and 48 hr after 250 µg/ml ESP105 treatment also showed no 
effect of saponin extracts on apoptosis induction (data not shown). These results suggest that M. 
truncatula saponins do not decrease cell proliferation through apoptosis induction but are not conclusive. 
Saponins have been shown to decrease cell proliferation through a variety of mechanisms that are likely 
to be related to structure (Bachran et al., 2008; Podolak et al., 2010). In these experiments, Caco-2 cells 
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were treated with a complex mixture of structurally diverse saponins that could each decrease 
proliferation through a variety of mechanisms. Saponins that decrease cell proliferation through apoptosis 
induction could have been present in the extracts but at such low concentrations that the level of 
apoptosis they might have caused was not sufficient to be detected by the assay used. The experiments 
performed also lacked a positive control. Treatment of Caco-2 cells with a compound previously shown to 
induce apoptosis, such as butyrate, would have confirmed that the particular Caco-2 cells used were 
responding to treatment and that the particular assay used was able to measure Caco-2 apoptosis 
induction. Additional investigation into the effects of M. truncatula saponin extracts on apoptosis induction 
using assays that involve other aspects of apoptosis besides caspase-3 could also be helpful.  
The existence of saponins that do not induce apoptosis and that act as anticancer agents through 
other mechanisms is not unprecedented. Soybean saponin treatment of HT-29 colon cancer cells 
resulted in decreased cell proliferation, suppressed protein kinase C activity, and induction of cell 
differentiation but did not induce apoptosis (Oh and Sung, 2001). Soybean produces some of the same 
sapogenins and saponins as M. truncatula, including soyasapogenol A, B and E and soyasaponin I (Jin et 
al., 2006). The soybean saponin treatment was later shown to decrease HT-29 colon cancer cell 
proliferation by suppressing inflammatory responses (Kim et al., 2004). Treatment of HCT-15 colon 
cancer cells with purified soybean B-group saponin extract decreased cell proliferation, caused cell cycle 
arrest, and induced autophagic Type II non-apoptotic programmed cell death (Ellington et al., 2005). A 
mixture of two steroidal saponins isolated from Balanites aegyptiaca demonstrated anti-proliferative 
effects on several cancer cells but did not induce apoptosis, instead causing major actin cytoskeleton 
disorganization by depleting ATP (Gnoula et al., 2008). Avicin D, a plant triterpenoid that has been shown 
to trigger apoptosis, was able to induce autophagic programmed cell death in tumor cells treated with an 
apoptosis inhibitor and in apoptosis-resistant knockout cells (Xu et al., 2007).  
Through HPLC-MS analysis, we found that extracts from the foliar tissue of M. truncatula A17, 
ESP105, PRT178, and GRC43 accession plants contained varying levels and types of triterpenoid 
saponins, and that treatment of Caco-2 human colon cancer cells with these extracts decreased cell 
proliferation in a dose- and time-dependent manner. This anti-proliferative effect did not appear to be 
mediated through caspase-3 activation leading to induction of apoptotic programmed cell death. The 
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remarkable complexity of cancer and the many mechanisms it uses to outwit the immune system and 
proliferate throughout the body, as well as the negative effects of many currently used chemotherapeutic 
drugs, has led to a constant demand for novel anticancer compounds. With their extensively studied 
cytotoxic effects, saponins may be able to satisfy this demand. Numerous studies on the in vitro effects of 
saponins on cancer cells have been conducted, and research on their in vivo effects, primarily in mice, is 
growing. For example, after being shown to significantly inhibit viability of human hepatoma, glioma, a 
gastric, breast, and colon carcinoma cell cultures, the hederagenin saponin macranthoside B isolated 
from Lonicera macranthoides was used to treat human hepatoma HepG2 xenograft tumors in nude mice 
by intravenous injection. Treatment significantly reduced tumor weight and volume as compared to the 
solvent-treated control and with comparable strength to cyclophosphamide, a chemotherapeutic drug 
(Wang et al., 2009). The steroidal saponin diosgenin isolated from fenugreek was incorporated into the 
diet of rats that had been injected with the carcinogen azoxymethane one-week prior to induce colon 
carcinogenesis. The diosgenin diet significantly suppressed invasive and non-invasive colon tumor 
incidence and decreased tumor multiplicity (Malisetty et al., 2005). In a similar study, a mixture of 
saponins isolated from soybean flour was used to supplement the diet of azoxymethane-treated mice and 
untreated mice. The saponin diet was not only able to significantly reduce incidence of precancerous 
aberrant crypt foci in azoxymethane-treated mice, but also showed no adverse effects on the growth and 
overall health of the untreated mice (Koratkar and Rao, 1997).  
To the author’s knowledge, this is the first study to show that saponin extracts from M. truncatula 
plants have cytotoxic activity and lays the foundation for further study of M. truncatula saponins and their 
possible future use as chemotherapeutic drugs. The saponin extracts used in this study, either from all 
four accessions or from the most anti-proliferative accessions, could be fractionated by preparative 
HPLC, and the cytotoxicity of those fractions assayed to identify the strongest anti-proliferative individual 
compounds. The mechanism through which the purified saponin compounds mediate their cytotoxic 
activity could then be evaluated without the interference of other saponins present in a complex mixture, 
and information on the structure of the purified saponin compounds could add to our knowledge of the 
relationship between saponin structure and cytotoxic activity. The effects of the M. truncatula saponin 
extracts used in this study or compounds purified from them on additional cancer cell types grown in 
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culture and the effect of M. truncatula saponin supplemented diets on colon carcinogenesis in 
azoxymethane-treated mice could be tested to further characerize the possibility of utilization of M. 
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